Page last updated: 2024-10-16

methane and Disease Models, Animal

methane has been researched along with Disease Models, Animal in 125 studies

Methane: The simplest saturated hydrocarbon. It is a colorless, flammable gas, slightly soluble in water. It is one of the chief constituents of natural gas and is formed in the decomposition of organic matter. (Grant & Hackh's Chemical Dictionary, 5th ed)
methane : A one-carbon compound in which the carbon is attached by single bonds to four hydrogen atoms. It is a colourless, odourless, non-toxic but flammable gas (b.p. -161degreeC).

Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.

Research Excerpts

ExcerptRelevanceReference
" Previous studies have proposed that oxidative stress, inflammation, and renal apoptosis are the most common causes of injury, whereas recent research proved that methane, the simplest alkane generated by an enteric microorganism or accompanying the production of reactive oxygen species (ROS), can alleviate inflammation and oxidative stress and reduce apoptosis in different organs."7.88Protective Effects of Methane-Rich Saline on Renal Ischemic-Reperfusion Injury in a Mouse Model. ( Cheng, T; Deng, X; Jiang, Z; Li, N; Liu, Y; Meng, Y; Wang, L; Yao, Y; Zhao, Z, 2018)
"The gold (I) N-heterocyclic carbene complex (C22H26N6AuO2PF6) designated as complex 3 induced ROS and p53 dependent apoptosis in B16F10 cells involving the mitochondrial death pathway along with suppression of melanoma tumor growth by regulating the levels of pro and anti apoptotic factors (p53, p21, NF-κB, VEGF and MMP-9)."7.80Gold (I) N-heterocyclic carbene complex inhibits mouse melanoma growth by p53 upregulation. ( Das, S; Dey, SK; Dinda, J; Munda, RN; Nandy, A; Saha, KD, 2014)
"The increasing incidence of multidrug-resistant (MDR) pulmonary infections in the cystic fibrosis (CF) population has prompted the investigation of innovative silver based therapeutics."7.75A theobromine derived silver N-heterocyclic carbene: synthesis, characterization, and antimicrobial efficacy studies on cystic fibrosis relevant pathogens. ( Cannon, CL; Han, DS; Hindi, KM; Panzner, MJ; Taylor, JB; Wright, BD; Youngs, WJ, 2009)
"Methane was mixed with air to achieve a final concentration of 2."5.46Inhaled Methane Protects Rats Against Neurological Dysfunction Induced by Cerebral Ischemia and Reperfusion Injury: PI3K/Akt/HO-1 Pathway Involved. ( Gao, M; He, D; Shen, J; Zhang, B, 2017)
"Methane treatment protected the rat brain from the harmful effects induced by CO exposure and improved the outcome of DNS through anti-oxidant, anti-inflammatory and anti-apoptosis activities."5.43Neuroprotective effects of exogenous methane in a rat model of acute carbon monoxide poisoning. ( Fan, DF; Hu, HJ; Lv, Y; Pan, SY; Sun, Q; Sun, XJ; Ye, ZH, 2016)
"Age, APACHE score at ICU admission, neurological disease, sepsis and duration of mechanical ventilation were all independent risk factors for the development of delirium in ICU patients."4.40Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. ( , 2023)
"How oxidative stress contributes to neuro-inflammation and chronic pain is documented, and methane is reported to protect against ischemia-reperfusion injury in the nervous system via anti-inflammatory and antioxidant properties."3.88Analgesic Effect of Methane Rich Saline in a Rat Model of Chronic Inflammatory Pain. ( Ji, F; Li, HL; Lv, H; Xu, H; Zhang, Y; Zhou, SZ; Zhou, YL, 2018)
" Previous studies have proposed that oxidative stress, inflammation, and renal apoptosis are the most common causes of injury, whereas recent research proved that methane, the simplest alkane generated by an enteric microorganism or accompanying the production of reactive oxygen species (ROS), can alleviate inflammation and oxidative stress and reduce apoptosis in different organs."3.88Protective Effects of Methane-Rich Saline on Renal Ischemic-Reperfusion Injury in a Mouse Model. ( Cheng, T; Deng, X; Jiang, Z; Li, N; Liu, Y; Meng, Y; Wang, L; Yao, Y; Zhao, Z, 2018)
"Single-wall and multi-wall carbon nanotubes complexed with chitosan improved the re-epithelialization of wounds, but an increase in fibrosis was detected."3.88Enhancement of wound healing by single-wall/multi-wall carbon nanotubes complexed with chitosan. ( Abu-Rass, H; Assali, M; Ghannam, L; Hindawi, R; Kittana, N; Lutz, S; Mousa, A; Zakarneh, M, 2018)
"The gold (I) N-heterocyclic carbene complex (C22H26N6AuO2PF6) designated as complex 3 induced ROS and p53 dependent apoptosis in B16F10 cells involving the mitochondrial death pathway along with suppression of melanoma tumor growth by regulating the levels of pro and anti apoptotic factors (p53, p21, NF-κB, VEGF and MMP-9)."3.80Gold (I) N-heterocyclic carbene complex inhibits mouse melanoma growth by p53 upregulation. ( Das, S; Dey, SK; Dinda, J; Munda, RN; Nandy, A; Saha, KD, 2014)
"The increasing incidence of multidrug-resistant (MDR) pulmonary infections in the cystic fibrosis (CF) population has prompted the investigation of innovative silver based therapeutics."3.75A theobromine derived silver N-heterocyclic carbene: synthesis, characterization, and antimicrobial efficacy studies on cystic fibrosis relevant pathogens. ( Cannon, CL; Han, DS; Hindi, KM; Panzner, MJ; Taylor, JB; Wright, BD; Youngs, WJ, 2009)
"In cancer patients with hypersplenism-related thrombocytopenia, PSAE is a safe intervention that effects a durable elevation in platelet counts across a range of malignancies and following the re-initiation of chemotherapy."2.73 ( Aasbrenn, M; Abd El-Aty, AM; Abdu, A; Abraha, HB; Achour, A; Acquaroni, M; Addeo, P; Agback, P; Agback, T; Al-Alwan, M; Al-Mazrou, A; Al-Mohanna, F; Aliste, M; Almquist, J; Andel, J; Ando, M; Angelov, A; Annuar, MSM; Antwi, K; Arroliga, AC; Arruda, SLM; Asch, SM; Averous, G; Ayaz, S; Ayer, GB; Bachellier, P; Ball, S; Banijamali, AR; Barden, TC; Bartoncini, S; Bedanie, G; Bellò, M; Benić, F; Berhe, GG; Bertiger, G; Beumer, JH; Bhandari, B; Bond, DS; Boules, M; Braüner Christensen, J; Brown-Johnson, C; Burgstaller, S; Cao, L; Capasso, C; Carlevato, R; Carvalho, AE; Ceci, F; Chagas, ATA; Chavan, SG; Chen, AP; Chen, HC; Chen, J; Chen, Q; Chen, Y; Chen, YF; Christ, ER; Chu, CW; Covey, JM; Coyne, GO'; Cristea, MC; Currie, MG; Dahdal, DN; Dai, L; Dang, Z; de Abreu, NL; de Carvalho, KMB; de la Plaza Llamas, R; Deandreis, D; Del Prete, S; Dennis, JA; Deur, J; Díaz Candelas, DA; Divyapriya, G; Djanani, A; Dodig, D; Doki, Y; Doroshow, JH; Dos Santos, RC; Durairaj, N; Dutra, ES; Eguchi, H; Eisterer, W; Ekmann, A; Elakkad, A; Evans, WE; Fan, W; Fang, Z; Faria, HP; Farris, SG; Fenoll, J; Fernandez-Botran, R; Flores, P; Fujita, J; Gan, L; Gandara, DR; Gao, X; Garcia, AA; Garrido, I; Gebru, HA; Gerger, A; Germano, P; Ghamande, S; Ghebeh, H; Giver Jensen, T; Go, A; Goichot, B; Goldwater, M; Gontero, P; Greil, R; Gruenberger, B; Guarneri, A; Guo, Y; Gupta, S; Haxholdt Lunn, T; Hayek, AJ; He, ML; Hellín, P; Hepprich, M; Hernández de Rodas, E; Hill, A; Hndeya, AG; Holdsworth, LM; Hookey, L; Howie, W; Hu, G; Huang, JD; Huang, SY; Hubmann, E; Hwang, SY; Imamura, H; Imperiale, A; Jiang, JQ; Jimenez, JL; Jin, F; Jin, H; Johnson, KL; Joseph, A; Juwara, L; Kalapothakis, E; Karami, H; Karayağiz Muslu, G; Kawabata, R; Kerwin, J; Khan, I; Khin, S; Kidanemariam, HG; Kinders, RJ; Klepov, VV; Koehler, S; Korger, M; Kovačić, S; Koyappayil, A; Kroll, MH; Kuban, J; Kummar, S; Kung, HF; Kurokawa, Y; Laengle, F; Lan, J; Leal, HG; Lee, MH; Lemos, KGE; Li, B; Li, G; Li, H; Li, X; Li, Y; Li, Z; Liebl, W; Lillaz, B; Lin, F; Lin, L; Lin, MCM; Lin, Y; Lin, YP; Lipton, RB; Liu, J; Liu, W; Liu, Z; Lu, J; Lu, LY; Lu, YJ; Ludwig, S; Luo, Y; Ma, L; Ma, W; Machado-Coelho, GLL; Mahmoodi, B; Mahoney, M; Mahvash, A; Mansour, FA; Mao, X; Marinho, CC; Masferrer, JL; Matana Kaštelan, Z; Melendez-Araújo, MS; Méndez-Chacón, E; Miletić, D; Miller, B; Miller, E; Miller, SB; Mo, L; Moazzen, M; Mohammadniaei, M; Montaz-Rosset, MS; Mousavi Khaneghah, A; Mühlethaler, K; Mukhopadhyay, S; Mulugeta, A; Nambi, IM; Navarro, S; Nazmara, S; Neumann, HJ; Newman, EM; Nguyen, HTT; Nicolato, AJPG; Nicolotti, DG; Nieva, JJ; Nilvebrant, J; Nocentini, A; Nugent, K; Nunez-Rodriguez, DL; Nygren, PÅ; Oberli, A; Oderda, M; Odisio, B; Oehler, L; Otludil, B; Overman, M; Özdemir, M; Pace, KA; Palm, H; Parchment, RE; Parise, R; Passera, R; Pavlovic, J; Pecherstorfer, M; Peng, Z; Pérez Coll, C; Petzer, A; Philipp-Abbrederis, K; Pichler, P; Piekarz, RL; Pilati, E; Pimentel, JDSM; Posch, F; Prager, G; Pressel, E; Profy, AT; Qi, P; Qi, Y; Qiu, C; Rajasekhar, B; Ramia, JM; Raynor, HA; Reis, VW; Reubi, JC; Ricardi, U; Riedl, JM; Romano, F; Rong, X; Rubinstein, L; Rumboldt, Z; Sabir, S; Safaeinili, N; Sala, BM; Sandoval Castillo, L; Sau, M; Sbhatu, DB; Schulte, T; Scott, V; Shan, H; Shao, Y; Shariatifar, N; Shaw, JG; She, Y; Shen, B; Shernyukov, A; Sheth, RA; Shi, B; Shi, R; Shum, KT; Silva, JC; Singh, A; Sinha, N; Sirajudeen, AAO; Slaven, J; Sliwa, T; Somme, F; Song, S; Steinberg, SM; Subramaniam, R; Suetta, C; Sui, Y; Sun, B; Sun, C; Sun, H; Sun, Y; Supuran, CT; Surger, M; Svartz, G; Takahashi, T; Takeno, A; Tam, AL; Tang, Z; Tanner, JA; Tannich, E; Taye, MG; Tekle, HT; Thomas, GJ; Tian, Y; Tobin, JV; Todd Milne, G; Tong, X; Une, C; Vela, N; Venkateshwaran, U; Villagrán de Tercero, CI; Wakefield, JD; Wampfler, R; Wan, M; Wang, C; Wang, J; Wang, L; Wang, S; Waser, B; Watt, RM; Wei, B; Wei, L; Weldemichael, MY; Wellmann, IA; Wen, A; Wild, D; Wilthoner, K; Winder, T; Wing, RR; Winget, M; Wöll, E; Wong, KL; Wong, KT; Wu, D; Wu, Q; Wu, Y; Xiang, T; Xiang, Z; Xu, F; Xu, L; Yamasaki, M; Yamashita, K; Yan, H; Yan, Y; Yang, C; Yang, H; Yang, J; Yang, N; Yang, Y; Yau, P; Yu, M; Yuan, Q; Zhan, S; Zhang, B; Zhang, H; Zhang, J; Zhang, N; Zhang, Y; Zhao, X; Zheng, BJ; Zheng, H; Zheng, W; Zhou, H; Zhou, X; Zhu, S; Zimmer, DP; Zionts, D; Zitella, A; Zlott, J; Zolfaghari, K; Zuo, D; Zur Loye, HC; Žuža, I, 2007)
" Still, there was linear dose-response relationship for 8-oxo-7,8-dihydroguanine in lung tissue without obvious signs of a threshold."2.49Oxidatively damaged DNA in animals exposed to particles. ( Danielsen, PH; Jantzen, K; Loft, S; Møller, P; Roursgaard, M, 2013)
"Anaplasmosis is one of the most prevalent tick-borne diseases of cattle caused by Anaplasma marginale."1.56Balanced Th1/Th2 immune response induced by MSP1a functional motif coupled to multiwalled carbon nanotubes as anti-anaplasmosis vaccine in murine model. ( Barbosa, MB; Coutinho, LB; Faria, PCB; Furtado, CA; Goulart, LR; Ladeira, LO; Martins, EMDN; Martins, JR; Morais, MA; Pimentel, LS; Santos, PS; Souza, AG; Turini, CA, 2020)
"Atherosclerosis is the process that underlies heart attack and stroke."1.56Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis. ( Flores, AM; Hosseini-Nassab, N; Ingelsson, E; Jarr, KU; Koh, AL; Kojima, Y; Leeper, NJ; Lotfi, M; Nanda, V; Sinclair, R; Smith, BR; Tsantilas, P; Wang, Y; Weissman, IL; Wirka, R; Ye, J; Zeng, Y; Zhu, X, 2020)
"Methane treatment resulted in significantly higher renal blood flow during the extracorporeal circulation period compared to the non-treated group (63."1.51Methane inhalation reduces the systemic inflammatory response in a large animal model of extracorporeal circulation. ( Bari, G; Bogáts, G; Boros, M; Érces, D; Szűcs, S; Varga, G; Varga, Z, 2019)
"Reentrant ventricular arrhythmias are a major cause of sudden death in patients with structural heart disease."1.51Three-Dimensional Printed Biopatches With Conductive Ink Facilitate Cardiac Conduction When Applied to Disrupted Myocardium. ( Asirvatham, SJ; Gatenholm, P; Kapa, S; Karabulut, E; Kuzmenko, V; Livia, C; McLeod, CJ; Pedrotty, DM; Sugrue, AM; Vaidya, VR, 2019)
"Methane was mixed with air to achieve a final concentration of 2."1.46Inhaled Methane Protects Rats Against Neurological Dysfunction Induced by Cerebral Ischemia and Reperfusion Injury: PI3K/Akt/HO-1 Pathway Involved. ( Gao, M; He, D; Shen, J; Zhang, B, 2017)
"Colitis was induced by colonic instillation of trinitrobenzene sulfonic acid (TNBS) and the effects of 2-AG solution and various types of MWCNTs on the colonic tissue damage, inflammation, and oxidative stress were evaluated."1.46Application of carbon nanotubes as the carriers of the cannabinoid, 2-arachidonoylglycerol: Towards a novel treatment strategy in colitis. ( Arbabi, E; Atyabi, F; Dinarvand, R; Hassanzadeh, P, 2017)
"Methane treatment significantly improved the RGC loss and visual dysfunction following ONC."1.46Methane rescues retinal ganglion cells and limits retinal mitochondrial dysfunction following optic nerve crush. ( Chen, Z; Liu, L; Sun, Q; Wang, R; Wu, J; Xia, F; Xu, J; Zhang, Y, 2017)
"The potential damage of Alzheimer's disease (AD) in brain function has attracted extensive attention."1.46Label-Free Electrochemical Biosensor for Monitoring of Chloride Ion in an Animal Model of Alzhemier's Disease. ( Dong, H; Liu, W; Tian, Y; Zhang, L, 2017)
"Methane has been reported to play a protective role in ischemia-reperfusion injury via anti-oxidation, anti-inflammatory and anti-apoptotic activities."1.43Neuroprotective effects of methane-rich saline on experimental acute carbon monoxide toxicity. ( Cai, Z; Chen, Y; Fan, D; Gong, J; Liu, J; Liu, Y; Shen, M; Sun, X; Zang, Y; Zhu, K, 2016)
"Methane treatment protected the rat brain from the harmful effects induced by CO exposure and improved the outcome of DNS through anti-oxidant, anti-inflammatory and anti-apoptosis activities."1.43Neuroprotective effects of exogenous methane in a rat model of acute carbon monoxide poisoning. ( Fan, DF; Hu, HJ; Lv, Y; Pan, SY; Sun, Q; Sun, XJ; Ye, ZH, 2016)
"Iohexol 300 mgI/mL was administered followed by images obtained in diastole."1.42Delayed contrast enhancement imaging of a murine model for ischemia reperfusion with carbon nanotube micro-CT. ( Burk, LM; Kang, E; Lee, YZ; Lu, J; Wait, JM; Wang, KH; Willis, M; Zhou, O, 2015)
"The mechanisms governing CNT-induced lung inflammation are not fully understood but have been suggested to involve alveolar macrophages (AMs)."1.42MyD88 mediates in vivo effector functions of alveolar macrophages in acute lung inflammatory responses to carbon nanotube exposure. ( Birch, ME; Frank, EA; Yadav, JS, 2015)
"In this study, we examined the pulmonary fibrosis response to different length of MWCNT including short MWCNT (S-MWCNT, length=350-700nm) and long MWCNT (L-MWCNT, length=5-15μm) and investigated whether the epithelial-mesenchymal transition (EMT) occurred during MWCNT-induced pulmonary fibrosis."1.40Epithelial-mesenchymal transition involved in pulmonary fibrosis induced by multi-walled carbon nanotubes via TGF-beta/Smad signaling pathway. ( Chen, T; Chen, Z; Cui, X; Gao, X; Jia, G; Nie, H; Pu, J; Wang, H; Wang, Y; Yang, J, 2014)
"Defective autophagy in Alzheimer's disease (AD) promotes disease progression in diverse ways."1.40Single-walled carbon nanotubes alleviate autophagic/lysosomal defects in primary glia from a mouse model of Alzheimer's disease. ( Berg, M; Jiang, Y; Liang, XJ; Nixon, RA; Sato, Y; Wang, LR; Xue, X; Yang, DS, 2014)
"Mucopolysaccharidosis IIIA (MPS IIIA) is a lysosomal storage disorder caused by a deficiency in the activity of the lysosomal hydrolase, sulphamidase, an enzyme involved in the degradation of heparan sulphate."1.38Exocytosis is impaired in mucopolysaccharidosis IIIA mouse chromaffin cells. ( Brooks, DA; Hemsley, KM; Hopwood, JJ; Keating, DJ; Mackenzie, KD; Parkinson-Lawrence, EJ; Teo, EH; Winter, MA, 2012)
"Lung granulomas are associated with numerous conditions, including inflammatory disorders, exposure to environmental pollutants, and infection."1.37Novel murine model of chronic granulomatous lung inflammation elicited by carbon nanotubes. ( Barna, BP; Chen, P; Dobbs, L; Huizar, I; Kavuru, MS; Ke, PC; Kukoly, C; Malur, A; Midgette, YA; Podila, R; Rao, AM; Thomassen, MJ; Wingard, CJ, 2011)
"However, at present, a true anticancer vaccine remains elusive."1.37Effective colon cancer prophylaxis in mice using embryonic stem cells and carbon nanotubes. ( Iancu, C; Mocan, T, 2011)
"On the other hand, patients with bronchial asthma are sensitive to inhaled substances including particulate matters."1.35Effects of multi-walled carbon nanotubes on a murine allergic airway inflammation model. ( Hirano, S; Inoue, K; Koike, E; Nishikawa, M; Takano, H; Yanagisawa, R, 2009)
" The findings of current in vitro studies now suggest that bactericidal concentrations of SCC1 are not toxic to airway epithelial cells in primary culture."1.35In vitro and murine efficacy and toxicity studies of nebulized SCC1, a methylated caffeine-silver(I) complex, for treatment of pulmonary infections. ( Brody, SL; Cannon, CL; Capps, GH; Hindi, KM; Hogue, LA; Ibricevic, A; Kascatan-Nebioglu, A; Vajravelu, RK; Walter, MJ; Youngs, WJ, 2009)
"The mild CNT-induced lung inflammation translates via rapid but mild and transient activation of platelets into P-selectin-mediated systemic inflammation."1.34Enhanced peripheral thrombogenicity after lung inflammation is mediated by platelet-leukocyte activation: role of P-selectin. ( Dinsdale, D; Hoet, PH; Hoylaerts, MF; Nemery, B; Nemmar, A; Vandervoort, P, 2007)

Research

Studies (125)

TimeframeStudies, this research(%)All Research%
pre-19904 (3.20)18.7374
1990's0 (0.00)18.2507
2000's14 (11.20)29.6817
2010's92 (73.60)24.3611
2020's15 (12.00)2.80

Authors

AuthorsStudies
Qutob, HMH1
Saad, RA1
Bali, H1
Osailan, A1
Jaber, J1
Alzahrani, E1
Alyami, J1
Elsayed, H1
Alserihi, R1
Shaikhomar, OA1
Divya, KM1
Savitha, DP1
Krishna, GA1
Dhanya, TM1
Mohanan, PV1
Shah, SF1
Jafry, AT1
Hussain, G1
Kazim, AH1
Ali, M1
Rivani, E1
Endraswari, PD1
Widodo, ADW1
Khalil, MR1
Guldberg, R1
Nørgård, BM1
Uldbjerg, N1
Wehberg, S1
Fowobaje, KR1
Mashood, LO1
Ekholuenetale, M1
Ibidoja, OJ1
Romagnoli, A1
D'Agostino, M1
Pavoni, E1
Ardiccioni, C1
Motta, S1
Crippa, P1
Biagetti, G1
Notarstefano, V1
Rexha, J1
Perta, N1
Barocci, S1
Costabile, BK1
Colasurdo, G1
Caucci, S1
Mencarelli, D1
Turchetti, C1
Farina, M1
Pierantoni, L1
La Teana, A1
Al Hadi, R1
Cicconardi, F1
Chinappi, M1
Trucchi, E1
Mancia, F1
Menzo, S1
Morozzo Della Rocca, B1
D'Annessa, I1
Di Marino, D1
Choya, A1
de Rivas, B1
Gutiérrez-Ortiz, JI1
López-Fonseca, R1
Xu, S1
Cheng, B1
Huang, Z3
Liu, T4
Li, Y7
Jiang, L1
Guo, W2
Xiong, J1
Amirazodi, M1
Daryanoosh, F1
Mehrabi, A1
Gaeini, A1
Koushkie Jahromi, M1
Salesi, M1
Zarifkar, AH1
Studeny, P1
Netukova, M1
Nemcokova, M1
Klimesova, YM1
Krizova, D1
Kang, H1
Tao, Y1
Zhang, Q6
Sha, D1
Chen, Y6
Yao, J1
Gao, Y2
Liu, J9
Ji, L1
Shi, P1
Shi, C1
Wu, YL1
Wright, AI1
M El-Metwaly, N1
A Katouah, H1
El-Desouky, MG1
El-Bindary, AA1
El-Bindary, MA1
Kostakis, ID1
Raptis, DA1
Davidson, BR1
Iype, S1
Nasralla, D1
Imber, C1
Sharma, D2
Pissanou, T1
Pollok, JM1
Hughes, AM1
Sanderson, E1
Morris, T1
Ayorech, Z1
Tesli, M1
Ask, H1
Reichborn-Kjennerud, T1
Andreassen, OA1
Magnus, P1
Helgeland, Ø1
Johansson, S1
Njølstad, P1
Davey Smith, G1
Havdahl, A1
Howe, LD1
Davies, NM1
Amrillah, T1
Prasetio, A1
Supandi, AR1
Sidiq, DH1
Putra, FS1
Nugroho, MA1
Salsabilla, Z1
Azmi, R1
Grammatikopoulos, P1
Bouloumis, T1
Steinhauer, S1
Mironov, VS2
Bazhenova, TA2
Manakin, YV2
Yagubskii, EB2
Yakushev, IA1
Gilmutdinov, IF1
Simonov, SV1
Lan, K1
Yang, H2
Zheng, J2
Hu, H3
Zhu, T1
Zou, X1
Hu, B3
Liu, H5
Olokede, O1
Wu, H3
Holtzapple, M1
Gungor, O1
Kose, M1
Ghaemi, R1
Acker, M1
Stosic, A1
Jacobs, R1
Selvaganapathy, PR1
Ludwig, N1
Yerneni, SS1
Azambuja, JH1
Pietrowska, M1
Widłak, P1
Hinck, CS1
Głuszko, A1
Szczepański, MJ1
Kärmer, T1
Kallinger, I1
Schulz, D1
Bauer, RJ1
Spanier, G1
Spoerl, S1
Meier, JK1
Ettl, T1
Razzo, BM1
Reichert, TE1
Hinck, AP1
Whiteside, TL1
Wei, ZL1
Juan, W1
Tong, D1
Juan, LX1
Sa, LY1
Jie, HFM1
Xiao, G1
Xiang, LG1
Jie, HM1
Xu, C3
Yu, DN1
Yao, ZX1
Bigdeli, F1
Gao, XM1
Cheng, X1
Li, JZ1
Zhang, JW1
Wang, W5
Guan, ZJ1
Bu, Y2
Liu, KG1
Morsali, A1
Das, R1
Paul, R1
Parui, A1
Shrotri, A1
Atzori, C1
Lomachenko, KA1
Singh, AK1
Mondal, J1
Peter, SC1
Florimbio, AR1
Coughlin, LN1
Bauermeister, JA1
Young, SD1
Zimmerman, MA1
Walton, MA1
Bonar, EE1
Demir, D1
Balci, AB1
Kahraman, N1
Sunbul, SA1
Gucu, A1
Seker, IB1
Badem, S1
Yuksel, A1
Ozyazicioglu, AF1
Goncu, MT1
Zhang, H7
Zhou, H3
Deng, Z2
Luo, L2
Ong, SP1
Wang, C9
Xin, H1
Whittingham, MS1
Zhou, G1
Maemura, R1
Wakamatsu, M1
Matsumoto, K1
Sakaguchi, H1
Yoshida, N1
Hama, A1
Yoshida, T1
Miwata, S1
Kitazawa, H1
Narita, K1
Kataoka, S1
Ichikawa, D1
Hamada, M1
Taniguchi, R1
Suzuki, K1
Kawashima, N1
Nishikawa, E1
Narita, A1
Okuno, Y1
Nishio, N1
Kato, K1
Kojima, S1
Morita, K1
Muramatsu, H1
Takahashi, Y1
Yirgu, A1
Mekonnen, Y1
Eyado, A1
Staropoli, A1
Vinale, F1
Zac, J1
Zac, S1
Pérez-Padilla, R1
Remigio-Luna, A1
Guzmán-Boulloud, N1
Gochicoa-Rangel, L1
Guzmán-Valderrábano, C1
Thirión-Romero, I1
Statsenko, ME1
Turkina, SV1
Barantsevich, ER1
Karakulova, YV1
Baranova, NS1
Morzhukhina, MV1
Wang, Q3
Gu, Y1
Chen, C1
Qiao, L2
Pan, F1
Song, C1
Canetto, SS1
Entilli, L1
Cerbo, I1
Cipolletta, S1
Wu, Y8
Zhu, P1
Jiang, Y3
Zhang, X7
Wang, Z5
Xie, B1
Song, T1
Zhang, F2
Luo, A1
Li, S4
Xiong, X2
Han, J3
Peng, X2
Li, M2
Huang, L3
Chen, Q3
Fang, W1
Hou, Y1
Zhu, Y2
Ye, J3
Liu, L2
Islam, MR1
Sanderson, P1
Johansen, MP1
Payne, TE1
Naidu, R1
Cao, J1
Yang, J5
Niu, X1
Liu, X5
Zhai, Y1
Qiang, C1
Niu, Y1
Li, Z6
Dong, N1
Wen, B1
Ouyang, Z1
Zhang, Y12
Li, J13
Zhao, M3
Zhao, J3
Morici, P1
Rizzato, C1
Ghelardi, E1
Rossolini, GM1
Lupetti, A1
Gözüküçük, R1
Cakiroglu, B1
He, X1
Li, R2
Zhao, D2
Zhang, L9
Ji, X1
Fan, X1
Chen, J6
Wang, Y13
Luo, Y3
Zheng, D1
Xie, L1
Sun, S2
Cai, Z2
Liu, Q3
Ma, K1
Sun, X4
Drinkwater, JJ1
Davis, TME1
Turner, AW1
Davis, WA1
Suzuki, Y1
Mizuta, Y1
Mikagi, A1
Misawa-Suzuki, T1
Tsuchido, Y1
Sugaya, T1
Hashimoto, T1
Ema, K1
Hayashita, T1
Karpińska, G1
Dobrowolski, JC1
Yinda, CK1
Rector, A1
Zeller, M1
Conceição-Neto, N1
Heylen, E1
Maes, P1
Ghogomu, SM1
Van Ranst, M1
Matthijnssens, J1
Arthanari, SK1
Vanitha, J1
Ganesh, M1
Venkateshwaran, K1
de Lama Caro-Patón, G1
García-Salido, A1
Iglesias-Bouzas, MI1
Guillén, M1
Cañedo-Villaroya, E1
Martínez-Romera, I1
Serrano-González, A1
Casado-Flores, J1
Gale, P3
Chen, X6
Li, H7
Lucero-Prisno, DE1
Abdullah, AS1
Huang, J3
Laurence, C1
Liang, X2
Ma, Z1
Mao, Z1
Ren, R1
Wu, S2
Wang, N1
Wang, P3
Wang, T3
Yan, H2
Zou, Y1
Olsen, KM1
Gabler, NK1
Rademacher, CJ1
Schwartz, KJ1
Schweer, WP1
Gourley, GG1
Patience, JF1
Rauch, JC1
Stokes, RS1
Shike, DW1
Luebbe, KM1
Stalker, LA1
Klopfenstein, TJ2
Funston, RN1
Unger, PA1
Lighaam, LC1
Vermeulen, E1
Kruithof, S1
Makuch, M1
Culver, EL1
van Bruggen, R1
Remmerswaal, EBM1
Ten Berge, IJM1
Emmens, RW1
Niessen, HWM1
Barnes, E1
Wolbink, GJ1
van Ham, SM1
Rispens, T1
Liang, JX1
Lin, J1
Wang, X6
Zhang, T2
Venier, M1
Salamova, A1
Gonçales, VR1
Lian, J1
Gautam, S1
Tilley, RD1
Gooding, JJ1
Kandel, YR1
Bradley, CA1
Chilvers, MI1
Mathew, FM1
Tenuta, AU1
Smith, DL1
Wise, KA1
Mueller, DS1
Lu, N1
Lu, M3
Liu, P1
Xu, H4
Qiu, X2
Hu, S1
Bai, S1
Wu, J3
Xue, S1
Dai, X1
Dharmage, SC1
Abramson, MJ1
Erbas, B1
Bennett, CM1
Svanes, C1
Hui, J1
Axelrad, C1
Lowe, AJ1
Lodge, CJ1
Hoshi, M1
Osawa, Y1
Nakamoto, K1
Morita, N1
Yamamoto, Y1
Ando, T1
Tashita, C1
Nabeshima, T1
Saito, K1
Gianesello, L1
Del Prete, D1
Ceol, M1
Priante, G1
Calò, LA1
Anglani, F1
Vekaria, HJ1
Hubbard, WB1
Scholpa, NE1
Spry, ML1
Gooch, JL1
Prince, SJ1
Schnellmann, RG1
Sullivan, PG1
Hu, R1
Gu, Z2
Zhang, M3
Zhang, Z3
Peng, Y1
Feng, L1
Li, X11
Zhao, C1
Sarfaraz, K1
Gao, L1
Wang, H6
Wan, C1
Leng, J1
Yang, P2
Gao, X3
Gao, J1
Emam, HE1
Saad, NM1
Abdallah, AEM1
Ahmed, HB1
Palombo, M1
Ianus, A1
Guerreri, M1
Nunes, D1
Alexander, DC1
Shemesh, N1
Xiong, Q1
Liu, YS1
Hu, LX1
Shi, ZQ1
Ying, GG1
Chen, R1
Hong, X1
Yan, S1
Zha, J1
Gu, H1
Zhong, Q1
Zeng, Y2
Zhang, S3
Farghali, M1
Mayumi, M1
Syo, K1
Satoshi, A1
Seiichi, Y1
Takashima, S1
Ono, H1
Ap, Y1
Yamashiro, T1
Ahmed, MM1
Kotb, S1
Iwasaki, M1
Ihara, I1
Umetsu, K1
Quan, J1
Huang, K1
Gu, X1
Zhu, J3
Yan, Y3
Wu, P2
Yang, L1
Koók, L1
Nemestóthy, N1
Bélafi-Bakó, K1
Bakonyi, P1
Luo, X2
Li, Q2
Xia, Q1
Ye, W1
Ge, C1
Zakkula, A1
Pulipati, S1
Dittakavi, S1
Bestha, RM1
Zainuddin, M1
Trivedi, RK1
Mullangi, R1
Lo, GH1
Lin, CW1
Tai, CM1
Perng, DS1
Chen, IL1
Yeh, JH1
Lin, HC1
Rocha, GS1
Silva, MKL1
Cesarino, I1
Hazzaa, SM1
Abdelaziz, SAM1
Abd Eldaim, MA1
Abdel-Daim, MM1
Elgarawany, GE1
Larsson, P1
Ljuslinder, I1
Öhlund, D1
Myte, R1
Löfgren-Burström, A1
Zingmark, C1
Ling, A1
Edin, S1
Palmqvist, R1
Murthi, P1
Rajaraman, G1
Erwich, JJHM1
Dimitriadis, E1
Yoon, HG1
Oh, D1
Ahn, YC1
Noh, JM1
Pyo, H1
Cho, WK1
Song, YM1
Park, M1
Hwang, NY1
Sun, JM1
Kim, HK1
Zo, JI1
Shim, YM1
Persano, A1
Quaranta, F1
Taurino, A1
Siciliano, PA1
Iannacci, J1
Malekbala, MR1
Soltani, S1
Abdul Rashid, S1
Abdullah, LC1
Rashid, U1
Nehdi, IA1
Choong, TSY1
Teo, SH1
Xu, P1
Yan, F1
Zhao, Y5
Ying, L1
Quinzi, V1
Caruso, S1
Mummolo, S1
Nota, A1
Angelone, AM1
Mattei, A1
Gatto, R1
Marzo, G1
Xin, W1
Severino, J1
Venkert, A1
Yu, H2
Knorr, D1
Yang, JM1
Carlson, L1
Hicks, R1
De Rosa, I1
Beckmann, NA1
Bitsch, RG1
Schonhoff, M1
Siebenrock, KA1
Schwarze, M1
Jaeger, S1
Halim, AA1
Alsayed, B1
Embarak, S1
Yaseen, T1
Dabbous, S1
Fontaine, O1
Dueluzeau, R1
Raibaud, P1
Chabanet, C1
Popoff, MR1
Badoual, J1
Gabilan, JC1
Andremont, A1
Gómez, L1
Andrés, S1
Sánchez, J1
Alonso, JM1
Rey, J1
López, F1
Jiménez, A1
Yan, Z1
Zhou, L1
Wang, J8
Hu, K1
Guo, Z2
Song, Y1
Huang, H4
Yang, R1
Owen, TW1
Al-Kaysi, RO1
Bardeen, CJ1
Cheng, Q1
Cheng, T2
Zhou, X2
Wang, B4
Wu, X2
Yao, Y4
Ochiai, T1
Ishiguro, H2
Nakano, R2
Kubota, Y2
Hara, M1
Sunada, K1
Hashimoto, K1
Kajioka, J1
Fujishima, A1
Jiao, J3
Gai, QY3
Zang, YP2
Niu, LL2
Fu, YJ3
Yao, LP1
Qin, QP1
Wang, ZY1
Aleksic Sabo, V1
Knezevic, P1
Borges-Argáez, R1
Chan-Balan, R1
Cetina-Montejo, L1
Ayora-Talavera, G1
Sansores-Peraza, P1
Gómez-Carballo, J1
Cáceres-Farfán, M1
Jang, J1
Akin, D1
Bashir, R1
Yu, Z1
Jiang, H1
He, C2
Xiao, Z1
Xu, J3
Sun, Q3
Han, D1
Lei, H1
Zhao, K2
Zhu, L1
Fu, H2
Wilson, BK1
Step, DL1
Maxwell, CL1
Gifford, CA1
Richards, CJ1
Krehbiel, CR1
Warner, JM1
Doerr, AJ1
Erickson, GE1
Guretzky, JA1
Rasby, RJ1
Watson, AK1
Sun, Y6
Liu, Z7
Pham, TD1
Lee, BK1
Yang, FC1
Wu, KH1
Lin, WP1
Hu, MK1
Lin, L4
Shao, J1
Sun, M1
Xu, G1
Xu, N1
Wang, R2
Liu, S2
He, H1
Dong, X2
Yang, M2
Yang, Q1
Duan, S1
Yu, Y3
Zhang, C3
Chen, L2
Yang, X2
Li, W3
Campbell, DA1
Gao, K1
Zager, RA1
Johnson, ACM1
Guillem, A1
Keyser, J1
Singh, B1
Steubl, D1
Schneider, MP1
Meiselbach, H1
Nadal, J1
Schmid, MC1
Saritas, T1
Krane, V1
Sommerer, C1
Baid-Agrawal, S1
Voelkl, J1
Kotsis, F1
Köttgen, A1
Eckardt, KU1
Scherberich, JE1
Yao, L2
Sun, L3
Zhu, Z1
Naren, N1
Zhang, XX2
Gentile, GL1
Rupert, AS1
Carrasco, LI1
Garcia, EM1
Kumar, NG1
Walsh, SW1
Jefferson, KK1
Guest, RL1
Samé Guerra, D1
Wissler, M1
Grimm, J1
Silhavy, TJ1
Lee, JH2
Yoo, JS1
Kim, Y1
Kim, JS2
Lee, EJ1
Roe, JH1
Delorme, M1
Bouchard, PA1
Simon, M1
Simard, S1
Lellouche, F1
D'Urzo, KA1
Mok, F1
D'Urzo, AD1
Koneru, B1
Lopez, G1
Farooqi, A1
Conkrite, KL1
Nguyen, TH1
Macha, SJ1
Modi, A1
Rokita, JL1
Urias, E1
Hindle, A1
Davidson, H1
Mccoy, K1
Nance, J1
Yazdani, V1
Irwin, MS1
Yang, S2
Wheeler, DA1
Maris, JM1
Diskin, SJ1
Reynolds, CP1
Abhilash, L1
Kalliyil, A1
Sheeba, V1
Hartley, AM2
Meunier, B2
Pinotsis, N1
Maréchal, A2
Xu, JY1
Genko, N1
Haraux, F1
Rich, PR1
Kamalanathan, M1
Doyle, SM1
Achberger, AM1
Wade, TL1
Schwehr, K1
Santschi, PH1
Sylvan, JB1
Quigg, A1
Leong, W1
Xu, W2
Gao, S1
Zhai, X1
Gilson, E1
Lu, Y2
Yan, R1
Hu, Z1
You, Q1
Cai, Q1
Yang, D2
Gu, S1
Dai, H3
Zhao, X3
Gui, C1
Gui, J1
Wu, PK1
Hong, SK1
Starenki, D1
Oshima, K1
Shao, H1
Gestwicki, JE1
Tsai, S1
Park, JI1
Zhao, R1
Dong, C2
Guo, G1
Li, L5
Barrett, HE1
Meester, EJ1
van Gaalen, K1
van der Heiden, K1
Krenning, BJ1
Beekman, FJ1
de Blois, E1
de Swart, J1
Verhagen, HJ1
Maina, T1
Nock, BA1
Norenberg, JP1
de Jong, M1
Gijsen, FJH1
Bernsen, MR1
Martínez-Milla, J1
Galán-Arriola, C1
Carnero, M1
Cobiella, J1
Pérez-Camargo, D1
Bautista-Hernández, V1
Rigol, M1
Solanes, N1
Villena-Gutierrez, R1
Lobo, M1
Mateo, J1
Vilchez-Tschischke, JP1
Salinas, B1
Cussó, L1
López, GJ1
Fuster, V1
Desco, M1
Sanchez-González, J1
Ibanez, B1
van den Berg, P1
Schweitzer, DH1
van Haard, PMM1
Geusens, PP1
van den Bergh, JP1
Zhu, X2
Huang, X3
Yang, G2
Lin, Z1
Salem, HF1
Nafady, MM1
Kharshoum, RM1
Abd El-Ghafar, OA1
Farouk, HO1
Domiciano, D1
Nery, FC1
de Carvalho, PA1
Prudente, DO1
de Souza, LB1
Chalfun-Júnior, A1
Paiva, R1
Marchiori, PER1
An, Z1
Jiang, J3
Du, S1
Cui, J2
Wu, W1
Liu, Y10
Song, J1
Lian, Q1
Uddin Ahmad, Z1
Gang, DD1
Konggidinata, MI1
Gallo, AA1
Zappi, ME1
Yang, TWW1
Johari, Y1
Burton, PR1
Earnest, A1
Shaw, K1
Hare, JL1
Brown, WA1
Kim, GA1
Han, S1
Choi, GH1
Choi, J1
Lim, YS1
Gallo, A1
Cancelli, C1
Ceron, E1
Covino, M1
Capoluongo, E1
Pocino, K1
Ianiro, G1
Cammarota, G1
Gasbarrini, A1
Montalto, M1
Somasundar, Y1
Lu, IC1
Mills, MR1
Qian, LY1
Olivares, X1
Ryabov, AD1
Collins, TJ1
Zhao, L1
Doddipatla, S1
Thomas, AM1
Nikolayev, AA1
Galimova, GR1
Azyazov, VN1
Mebel, AM1
Kaiser, RI1
Guo, S1
Yu, X3
Yu, B2
Han, B1
George, MW1
Moor, MB1
Bonny, O1
Langenberg, E1
Paik, H1
Smith, EH1
Nair, HP1
Hanke, I1
Ganschow, S1
Catalan, G1
Domingo, N1
Schlom, DG1
Assefa, MK1
Wu, G2
Hayton, TW1
Becker, B1
Enikeev, D1
Netsch, C1
Gross, AJ1
Laukhtina, E1
Glybochko, P1
Rapoport, L1
Herrmann, TRW1
Taratkin, M1
Dai, W1
Shi, J2
Carreno, J1
Kloner, RA1
Pickersgill, NA1
Vetter, JM1
Kim, EH1
Cope, SJ1
Du, K1
Venkatesh, R1
Giardina, JD1
Saad, NES1
Bhayani, SB1
Figenshau, RS1
Eriksson, J1
Landfeldt, E1
Ireland, S1
Jackson, C1
Wyatt, E1
Gaudig, M1
Stancill, JS1
Happ, JT1
Broniowska, KA1
Hogg, N1
Corbett, JA1
Tang, LF1
Bi, YL1
Fan, Y3
Sun, YB1
Wang, AL1
Xiao, BH1
Wang, LF1
Qiu, SW1
Guo, SW1
Wáng, YXJ1
Sun, J2
Chu, S1
Pan, Q1
Li, D2
Zheng, S2
Ma, L2
Wang, L8
Hu, T1
Wang, F1
Han, Z1
Yin, Z1
Ge, X1
Xie, K1
Lei, P1
Dias-Santagata, D1
Lennerz, JK1
Sadow, PM1
Frazier, RP1
Govinda Raju, S1
Henry, D1
Chung, T1
Kherani, J1
Rothenberg, SM1
Wirth, LJ1
Marti, CN1
Choi, NG1
Bae, SJ1
Ni, L1
Dai, T1
Yang, Y5
Lee, R1
Fleischer, AS1
Wemhoff, AP1
Ford, CR1
Kleppinger, EL1
Helms, K1
Bush, AA1
Luna-Abanto, J1
García Ruiz, L1
Laura Martinez, J1
Álvarez Larraondo, M1
Villoslada Terrones, V1
Dukic, L1
Maric, N1
Simundic, AM1
Chogtu, B1
Ommurugan, B1
Thomson, SR1
Kalthur, SG1
Benidir, M1
El Massoudi, S1
El Ghadraoui, L1
Lazraq, A1
Benjelloun, M1
Errachidi, F1
Cassar, M1
Law, AD1
Chow, ES1
Giebultowicz, JM1
Kretzschmar, D1
Salonurmi, T1
Nabil, H1
Ronkainen, J1
Hyötyläinen, T1
Hautajärvi, H1
Savolainen, MJ1
Tolonen, A1
Orešič, M1
Känsäkoski, P1
Rysä, J1
Hakkola, J1
Hukkanen, J1
Zhu, N1
Du, Q1
Hao, P1
Cao, X1
Li, CX1
Zhao, S1
Luo, XM1
Feng, JX1
Gonzalez-Cotto, M1
Guo, L1
Karwan, M1
Sen, SK1
Barb, J1
Collado, CJ1
Elloumi, F1
Palmieri, EM1
Boelte, K1
Kolodgie, FD1
Finn, AV1
Biesecker, LG1
McVicar, DW1
Qu, F1
Xie, Y2
Tang, J3
Chen, Z4
Luo, W1
Xiong, D1
Fang, J1
Zhou, Z1
Niu, PP1
Song, B1
Xu, YM1
Qiu, N1
Yin, J1
Zhang, J5
Liu, M3
Chen, D5
Luo, K1
He, Z2
Zheng, G1
Xu, F2
Sun, W2
Yin, F1
van Hest, JCM1
Du, L2
Shi, X2
Kang, S1
Duan, W1
Feng, J2
Qi, N1
Shen, G1
Ren, H2
Shang, Q1
Zhao, W2
Yang, Z3
Jiang, X2
Alame, M1
Cornillot, E1
Cacheux, V1
Tosato, G1
Four, M1
De Oliveira, L1
Gofflot, S1
Delvenne, P1
Turtoi, E1
Cabello-Aguilar, S1
Nishiyama, M1
Turtoi, A1
Costes-Martineau, V1
Colinge, J1
Guo, Q2
Quan, M1
Dong, J2
Bai, J1
Han, R1
Cai, Y1
Lv, YQ1
Lyu, HD1
Deng, L1
Zhou, D1
Xiao, X1
De Langhe, S1
Billadeau, DD1
Lou, Z1
Zhang, JS1
Xue, Z1
Shen, XD1
Gao, F1
Busuttil, RW1
Kupiec-Weglinski, JW1
Ji, H1
Otano, I1
Alvarez, M1
Minute, L1
Ochoa, MC1
Migueliz, I1
Molina, C1
Azpilikueta, A1
de Andrea, CE1
Etxeberria, I1
Sanmamed, MF1
Teijeira, Á1
Berraondo, P1
Melero, I1
Zhong, Z1
Xie, X1
Yu, Q1
Zhou, C2
Liu, C3
Liu, W3
Chen, W1
Yin, Y1
Li, CW1
Hsu, JL1
Zhou, Q2
Fu, P1
Atyah, M1
Ma, Q2
Xu, Y1
Dong, Q1
Hung, MC1
Ren, N1
Huang, P1
Liao, R1
Cao, Q1
Yuan, X1
Nie, W1
Shao, B1
Ma, X1
Bi, Z1
Tie, Y1
Mo, F1
Xie, D1
Wei, Y1
Wei, X2
Dokla, EME1
Fang, CS1
Chu, PC1
Chang, CS1
Abouzid, KAM1
Chen, CS1
Blaszczyk, R1
Brzezinska, J1
Dymek, B1
Stanczak, PS1
Mazurkiewicz, M1
Olczak, J1
Nowicka, J1
Dzwonek, K1
Zagozdzon, A1
Golab, J1
Golebiowski, A1
Xin, Z1
Himmelbauer, MK1
Jones, JH1
Enyedy, I1
Gilfillan, R1
Hesson, T1
King, K1
Marcotte, DJ1
Murugan, P1
Santoro, JC1
Gonzalez-Lopez de Turiso, F1
Pedron, J1
Boudot, C1
Brossas, JY1
Pinault, E1
Bourgeade-Delmas, S1
Sournia-Saquet, A1
Boutet-Robinet, E1
Destere, A1
Tronnet, A1
Bergé, J1
Bonduelle, C1
Deraeve, C1
Pratviel, G1
Stigliani, JL1
Paris, L1
Mazier, D1
Corvaisier, S1
Since, M1
Malzert-Fréon, A1
Wyllie, S1
Milne, R1
Fairlamb, AH1
Valentin, A1
Courtioux, B1
Verhaeghe, P1
Fang, X1
Gao, M2
Gao, H3
Bi, W1
Tang, H1
Cui, Y1
Fan, H1
Mathison, CJN1
Chianelli, D1
Rucker, PV1
Nelson, J1
Roland, J1
Xie, YF1
Epple, R1
Bursulaya, B1
Lee, C1
Gao, MY1
Shaffer, J1
Briones, S1
Sarkisova, Y1
Galkin, A1
Li, N3
Li, C2
Hua, S1
Kasibhatla, S1
Kinyamu-Akunda, J1
Kikkawa, R1
Molteni, V1
Tellew, JE1
Jin, X1
Pang, B1
Huang, Y2
Josephine Fauci, A1
Ma, Y1
Soo Lee, M1
Yuan, W1
Gao, R1
Qi, H1
Zheng, W2
Yang, F3
Chua, H1
Wang, K1
Ou, Y1
Huang, M1
Yu, J2
Tian, J1
Hu, J2
Yao, C1
Zhang, B3
Usawachintachit, M1
Tzou, DT1
Washington, SL1
Hu, W1
Chi, T1
Sorensen, MD1
Bailey, MR1
Hsi, RS1
Cunitz, BW1
Simon, J1
Wang, YN1
Dunmire, BL1
Paun, M1
Starr, F1
Lu, W2
Evan, AP1
Harper, JD1
Han, G1
Rodrigues, AE1
Fouladvand, F1
Falahi, E1
Asbaghi, O1
Abbasnezhad, A1
Anigboro, AA1
Avwioroko, OJ1
Cholu, CO1
Sonei, A1
Fazelipour, S1
Kanaani, L1
Jahromy, MH1
Jo, K1
Hong, KB1
Suh, HJ1
Park, JH3
Shin, E1
Park, E1
Kouakou-Kouamé, CA1
N'guessan, FK1
Montet, D1
Djè, MK1
Kim, GD1
González-Fernández, D1
Pons, EDC1
Rueda, D1
Sinisterra, OT1
Murillo, E1
Scott, ME1
Koski, KG1
Shete, PB1
Gonzales, R1
Ackerman, S1
Cattamanchi, A1
Handley, MA1
Li, XX1
Xiao, SZ1
Gu, FF1
He, WP1
Ni, YX1
Han, LZ1
Heffernan, JK1
Valgepea, K1
de Souza Pinto Lemgruber, R1
Casini, I1
Plan, M1
Tappel, R1
Simpson, SD1
Köpke, M1
Nielsen, LK1
Marcellin, E1
Cen, YK1
Lin, JG1
Wang, YL1
Wang, JY1
Liu, ZQ1
Zheng, YG1
Spirk, D1
Noll, S1
Burnier, M1
Rimoldi, S1
Noll, G1
Sudano, I1
Penzhorn, BL1
Oosthuizen, MC1
Kobos, LM1
Alqatani, S1
Ferreira, CR1
Aryal, UK1
Hedrick, V1
Sobreira, TJP1
Shannahan, JH1
Singhroy, DN1
MacLean, E1
Kohli, M1
Lessem, E1
Branigan, D1
England, K1
Suleiman, K1
Drain, PK1
Ruhwald, M1
Schumacher, S1
Denkinger, CM1
Waning, B1
Van Gemert, W1
Pai, M1
Myers, RK1
Bonsu, JM1
Carey, ME1
Yerys, BE1
Mollen, CJ1
Curry, AE1
Douglas, TA1
Alinezhadbalalami, N1
Balani, N1
Schmelz, EM1
Davalos, RV1
Kamaldinov, T1
Erndt-Marino, J1
Levin, M1
Kaplan, DL1
Hahn, MS1
Heidarimoghadam, R1
Farmany, A1
Lee, JJ1
Kang, J1
Park, S1
Cho, JH1
Oh, S1
Park, DJ1
Perez-Maldonado, R1
Cho, JY1
Park, IH1
Kim, HB1
Song, M1
Mfarrej, B1
Jofra, T1
Morsiani, C1
Gagliani, N1
Fousteri, G1
Battaglia, M1
Giuliano, C1
Levinger, I1
Vogrin, S1
Neil, CJ1
Allen, JD1
Lv, Y2
Yuan, R1
Cai, B1
Bahrami, B1
Chowdhury, AH1
Yang, C3
Qiao, Q1
Liu, SF1
Zhang, WH1
Kolano, L1
Knappe, D1
Volke, D1
Sträter, N1
Hoffmann, R1
Coussens, M1
Calders, P1
Lapauw, B1
Celie, B1
Banica, T1
De Wandele, I1
Pacey, V1
Malfait, F1
Rombaut, L1
Vieira, D1
Angel, S1
Honjol, Y1
Gruenheid, S1
Gbureck, U1
Harvey, E1
Merle, G1
Seo, G1
Lee, G1
Kim, MJ1
Baek, SH1
Choi, M1
Ku, KB1
Lee, CS1
Jun, S1
Park, D1
Kim, HG1
Kim, SJ1
Lee, JO1
Kim, BT1
Park, EC1
Kim, SI1
Ende, M1
Kirkkala, T1
Loitzenbauer, M1
Talla, D1
Wildner, M1
Miletich, R1
Criado, A1
Lavela, P1
Tirado, JL1
Pérez-Vicente, C1
Kang, D1
Feng, D2
Fang, Z2
Wei, F1
De Clercq, E1
Pannecouque, C1
Zhan, P1
Guo, Y2
Shen, Y1
Kawazoe, Y1
Jena, P1
Sun, Z1
Liang, H1
Xu, X1
Ma, G1
Huo, X1
Church, JS1
Chace-Donahue, F1
Blum, JL1
Ratner, JR1
Zelikoff, JT1
Schwartzer, JJ1
Fiseha, T1
Tamir, Z1
Yao, W1
Mi, K1
Cheng, J1
Gu, C1
Sun, HB1
Xing, WQ1
Liu, XB1
Zheng, Y1
Yang, SJ1
Wang, ZF1
Liu, SL1
Ba, YF1
Zhang, RX1
Liu, BX1
Fan, CC1
Chen, PN1
Liang, GH1
Yu, YK1
Wang, HR1
Li, HM1
Li, ZX1
Lalani, SS1
Anasir, MI1
Poh, CL1
Khan, IT1
Nadeem, M1
Imran, M1
Khalique, A1
Raspini, B1
Porri, D1
De Giuseppe, R1
Chieppa, M1
Liso, M1
Cerbo, RM1
Civardi, E1
Garofoli, F1
Monti, MC1
Vacca, M1
De Angelis, M1
Cena, H1
Kong, D1
Han, X1
Zhou, Y3
Xue, H1
Zhang, W1
Ruan, Z1
Noer, PR1
Kjaer-Sorensen, K1
Juhl, AK1
Goldstein, A1
Ke, C1
Oxvig, C1
Duan, C2
Kong, F1
Lin, S2
Bhattacharya, R1
Mazumder, D1
Yan, X1
Ma, C1
Tang, Y1
Kong, X1
Lu, J5
Vital-Jacome, M1
Cazares-Granillo, M1
Carrillo-Reyes, J1
Buitron, G1
Jacob, SI1
Douair, I1
Maron, L1
Ménard, G1
Rusjan, P1
Sabioni, P1
Di Ciano, P1
Mansouri, E1
Boileau, I1
Laveillé, A1
Capet, M1
Duvauchelle, T1
Schwartz, JC1
Robert, P1
Le Foll, B1
Xia, Y1
Chen, S1
Luo, M1
Cai, S1
He, Y2
Garbacz, P1
Misiak, M1
Jackowski, K1
Yuan, Q2
Sherrell, PC1
Bi, X1
Nutho, B1
Mahalapbutr, P1
Hengphasatporn, K1
Pattaranggoon, NC1
Simanon, N1
Shigeta, Y1
Hannongbua, S1
Rungrotmongkol, T1
Caffrey, PJ1
Kher, R1
Bian, K1
Delaney, S1
Xue, J1
Xu, L2
Yuan, Y1
Luo, J1
Ye, S1
Ustriyana, P1
Wei, B2
Raee, E1
Hu, Y2
Wesdemiotis, C1
Sahai, N1
Kaur, A1
Nigam, K1
Srivastava, S1
Tyagi, A1
Dang, S1
Millar, JE1
Bartnikowski, N1
Passmore, MR1
Obonyo, NG1
Malfertheiner, MV1
von Bahr, V1
Redd, MA1
See Hoe, L1
Ki, KK1
Pedersen, S1
Boyle, AJ1
Baillie, JK1
Shekar, K1
Palpant, N1
Suen, JY1
Matthay, MA1
McAuley, DF1
Fraser, JF1
Settles, JA1
Gerety, GF1
Spaepen, E1
Suico, JG1
Child, CJ1
Oh, BL1
Lee, JS1
Lee, EY1
Lee, HY2
Yu, HG1
Leslie, I1
Boos, LA1
Larkin, J1
Pickering, L1
Lima, HK1
Vogel, K1
Hampel, D1
Wagner-Gillespie, M1
Fogleman, AD1
Ferraz, SL1
O'Connor, M1
Mazzucchelli, TG1
Kajiyama, H1
Suzuki, S1
Shimbo, A1
Utsumi, F1
Yoshikawa, N1
Kikkawa, F1
Javvaji, PK1
Dhali, A1
Francis, JR1
Kolte, AP1
Roy, SC1
Selvaraju, S1
Mech, A1
Sejian, V1
DeSilva, S1
Vaidya, SS1
Mao, C1
Akhatayeva, Z1
Cheng, H1
Zhang, G1
Jiang, F1
Meng, X1
Elnour, IE1
Lan, X1
Song, E1
Rohde, S1
Antonides, CFJ1
Muslem, R1
de Woestijne, PCV1
der Meulen, MHV1
Kraemer, US1
Dalinghaus, M1
Bogers, AJJC1
Pourmand, A1
Ghassemi, M1
Sumon, K1
Amini, SB1
Hood, C1
Sikka, N1
Duan, H1
Chen, WP1
Fan, M1
Wang, WP1
Yu, L1
Tan, SJ1
Xin, S1
Wan, LJ1
Guo, YG1
Tanda, S1
Gingl, K1
Ličbinský, R1
Hegrová, J1
Goessler, W1
Li, ZL1
Zhou, YL2
Yan, W1
Su, ZZ1
Fan, MZ1
Wang, SR1
Zhao, WG1
Xu, D1
Hassan, HM1
Jiang, Z2
Bachmann, KF1
Haenggi, M1
Jakob, SM1
Takala, J1
Gattinoni, L1
Berger, D1
Bentley, RF1
Vecchiarelli, E1
Banks, L1
Gonçalves, PEO1
Thomas, SG1
Goodman, JM1
Mather, K1
Boachie, R1
Anini, Y1
Panahi, S1
Anderson, GH1
Luhovyy, BL1
Nafie, MS1
Arafa, K1
Sedky, NK1
Alakhdar, AA1
Arafa, RK1
Fan, S1
Liang, J1
Hu, BC1
Wen, Z1
Hu, D1
Liu, YY1
Chu, Q1
Wu, MC1
Lu, X1
Wang, D2
Hu, M1
Shen, H1
Yao, M1
Dahlgren, RA1
Vysloužil, J1
Kulich, P1
Zeman, T1
Vaculovič, T1
Tvrdoňová, M1
Mikuška, P1
Večeřa, Z1
Stráská, J1
Moravec, P1
Balcar, VJ1
Šerý, O1
Duan, J1
Xiao, W1
Zhou, HY1
Sui, ZY1
Zhao, FL1
Sun, YN1
Wang, HY1
Han, BH1
Jintao, X1
Shasha, Y1
Jincai, W1
Chunyan, L1
Mengya, Y1
Yongli, S1
Rasoanirina, BNV1
Lassoued, MA1
Miladi, K1
Razafindrakoto, Z1
Chaâbane-Banaoues, R1
Ramanitrahasimbola, D1
Cornet, M1
Sfar, S1
Liang, C2
Xing, Q1
Yi, JL1
Zhang, YQ1
Li, CY1
Tang, SJ1
Gao, C1
Peng, M1
Sun, XF1
Shi, JH1
Liao, CX1
Gao, WJ1
Sun, LL1
Cao, WH1
Lyu, J1
Yu, CQ1
Wang, SF1
Pang, ZC1
Cong, LM1
Dong, Z1
Wu, F1
Wu, XP1
Jiang, GH1
Wang, XJ1
Wang, BY1
Li, LM1
Pan, L1
Wan, SP1
Yi, HWL1
He, HJ1
Yong, ZP1
Shan, GL1
Weng, TT1
Yan, SQ1
Gao, GP1
Wei, C2
Tao, FB1
Shao, ZH1
Yao, T1
Dong, S1
Shi, S1
Feng, YL1
Zhang, YW1
Wang, SP1
Shi, AX1
Operario, D1
Zhang, ZH1
Zhu, XF1
Zaller, N1
Gao, P1
Sun, YH1
Zhang, HB1
Shen, N1
Xia, F1
Sun, A1
Xie, N1
Xi, Y1
Ye, X1
Zou, T1
Lok, CN1
Wan, PK1
Zhang, ZF1
Fung, SK1
Che, CM1
Zhou, SZ1
Ji, F1
Li, HL1
Lv, H1
Shen, J1
He, D1
Poles, MZ2
Bódi, N1
Bagyánszki, M1
Fekete, É1
Mészáros, AT2
Varga, G5
Szűcs, S4
Nászai, A1
Kiss, L1
Kozlov, AV1
Boros, M6
Kaszaki, J4
Meng, Y2
Zhao, Z1
Deng, X2
Bari, G2
Érces, D3
Varga, Z1
Bogáts, G1
Zhang, D1
Ugocsai, M1
Lashkarivand, RA1
Lajkó, N1
Mohácsi, Á2
Szabó, A2
Nayak, D1
Katoch, A1
Faheem, MM1
Chakraborty, S1
Sahu, PK1
Chikan, NA1
Amin, H1
Gupta, AP1
Gandhi, SG1
Mukherjee, D1
Goswami, A1
Tuboly, E3
Erős, G1
Szabó, G1
Tengölics, R1
Rákhely, G1
Nandy, A1
Dey, SK1
Das, S1
Munda, RN1
Dinda, J1
Saha, KD1
Fan, DF1
Hu, HJ1
Ye, ZH1
Sun, XJ1
Pan, SY1
Shen, M1
Fan, D1
Zang, Y1
Zhu, K1
Gong, J1
Büki, T1
Fazekas, B1
Horváth, K1
Cannon, CL2
Hogue, LA1
Vajravelu, RK1
Capps, GH1
Ibricevic, A1
Hindi, KM2
Kascatan-Nebioglu, A1
Walter, MJ1
Brody, SL1
Youngs, WJ2
Panzner, MJ1
Wright, BD1
Taylor, JB1
Han, DS1
Kashyap, VK1
Gupta, RK1
Shrivastava, R1
Srivastava, BS1
Srivastava, R1
Parai, MK1
Singh, P1
Bera, S1
Panda, G1
Ghyczy, M1
Ogawa, Y1
Okumura, K1
Matsui, H1
Fukami, Y1
Saburi, Y1
Iami, H1
Mizuno, T1
Nishimoto, Y1
Shifrin, AL1
Chirmule, N1
Raper, SE1
Hiramoto, T1
Chida, Y1
Sonoda, J1
Yoshihara, K1
Sudo, N1
Kubo, C1
Douay, O1
Kamoun, PP1
Aviado, DM1
Loyke, HF1
Jdah, JD1
McLean, AE1
McLean, EK1
Kunisaki, A1
Kodama, A1
Ishikawa, M1
Ueda, T1
Lima, MD1
Kondo, T1
Adachi, N1
Fraser, K1
Hubbs, A1
Yanamala, N1
Mercer, RR3
Stueckle, TA1
Jensen, J1
Eye, T1
Battelli, L1
Clingerman, S1
Fluharty, K1
Dodd, T1
Casuccio, G1
Bunker, K1
Lersch, TL1
Kashon, ML1
Orandle, M1
Dahm, M1
Schubauer-Berigan, MK1
Kodali, V1
Erdely, A1
Soliman, E1
Bhalla, S1
Elhassanny, AEM1
Malur, A8
Ogburn, D1
Leffler, N2
Malur, AG1
Thomassen, MJ7
You, DJ1
Taylor-Just, A1
Tisch, LJ1
Bartone, RD1
Atkins, HM1
Ralph, LM1
Antoniak, S1
Bonner, JC3
McCauley, MD1
Vitale, F1
Yan, JS1
Young, CC1
Greet, B1
Orecchioni, M1
Perike, S1
Elgalad, A1
Coco, JA1
John, M1
Taylor, DA1
Sampaio, LC1
Delogu, LG1
Razavi, M1
Pasquali, M1
Beyeler, S1
Steiner, S1
Wotzkow, C1
Tschanz, SA1
Adhanom Sengal, A1
Wick, P1
Haenni, B1
Alves, MP1
von Garnier, C1
Blank, F1
Pimentel, LS1
Turini, CA1
Santos, PS1
Morais, MA1
Souza, AG1
Barbosa, MB1
Martins, EMDN1
Coutinho, LB1
Furtado, CA1
Ladeira, LO1
Martins, JR1
Goulart, LR1
Faria, PCB1
Flores, AM1
Hosseini-Nassab, N1
Jarr, KU1
Wirka, R1
Koh, AL1
Tsantilas, P1
Nanda, V1
Kojima, Y1
Lotfi, M1
Sinclair, R2
Weissman, IL1
Ingelsson, E1
Smith, BR2
Leeper, NJ1
El-Sharkawy, RG1
Taha, RH1
Ghanem, HB1
Yang, N1
Tanner, JA1
Zheng, BJ1
Watt, RM1
He, ML1
Lu, LY1
Jiang, JQ1
Shum, KT1
Lin, YP1
Wong, KL1
Lin, MCM1
Kung, HF1
Sun, H2
Huang, JD1
Marinho, CC1
Nicolato, AJPG1
Reis, VW1
Dos Santos, RC1
Silva, JC1
Faria, HP1
Machado-Coelho, GLL1
Zhang, N1
Sun, B1
Wei, L1
Ball, S1
Dennis, JA1
Bedanie, G1
Nugent, K1
Hayek, AJ1
Scott, V1
Yau, P1
Zolfaghari, K1
Goldwater, M1
Almquist, J1
Arroliga, AC1
Ghamande, S1
Wu, Q1
Ma, W1
Shi, R1
Mao, X1
Sbhatu, DB1
Berhe, GG1
Hndeya, AG1
Abraha, HB1
Abdu, A1
Gebru, HA1
Taye, MG1
Mulugeta, A1
Weldemichael, MY1
Tekle, HT1
Kidanemariam, HG1
Surger, M1
Angelov, A1
Liebl, W1
Hookey, L1
Bertiger, G1
Johnson, KL1
Boules, M1
Ando, M1
Dahdal, DN1
Riedl, JM1
Posch, F1
Prager, G1
Eisterer, W1
Oehler, L1
Sliwa, T1
Wilthoner, K1
Petzer, A1
Pichler, P1
Hubmann, E1
Winder, T1
Burgstaller, S1
Korger, M1
Andel, J1
Greil, R1
Neumann, HJ1
Pecherstorfer, M1
Philipp-Abbrederis, K1
Djanani, A1
Gruenberger, B1
Laengle, F1
Wöll, E1
Gerger, A1
Evans, WE1
Raynor, HA1
Howie, W1
Lipton, RB1
Thomas, GJ1
Wing, RR1
Pavlovic, J1
Farris, SG1
Bond, DS1
Hepprich, M1
Antwi, K1
Waser, B1
Reubi, JC1
Wild, D1
Christ, ER1
Braüner Christensen, J1
Aasbrenn, M1
Sandoval Castillo, L1
Ekmann, A1
Giver Jensen, T1
Pressel, E1
Haxholdt Lunn, T1
Suetta, C1
Palm, H1
Mansour, FA1
Al-Mazrou, A1
Al-Mohanna, F1
Al-Alwan, M1
Ghebeh, H1
Brown-Johnson, C1
Safaeinili, N1
Zionts, D1
Holdsworth, LM1
Shaw, JG1
Asch, SM1
Mahoney, M1
Winget, M1
Shan, H1
Qi, P1
Li, B1
Rong, X1
Shen, B1
Lin, F1
Tang, Z1
Peng, Z1
Jimenez, JL1
Ayer, GB1
Klepov, VV1
Pace, KA1
Zur Loye, HC1
Acquaroni, M1
Svartz, G1
Pérez Coll, C1
Otludil, B1
Ayaz, S1
Hill, A1
Elakkad, A1
Kuban, J1
Sabir, S1
Odisio, B1
Huang, SY1
Mahvash, A1
Miller, E1
Kroll, MH1
Overman, M1
Tam, AL1
Gupta, S1
Sheth, RA1
Deandreis, D1
Guarneri, A1
Ceci, F1
Lillaz, B1
Bartoncini, S1
Oderda, M1
Nicolotti, DG1
Pilati, E1
Passera, R1
Zitella, A1
Bellò, M1
Parise, R1
Carlevato, R1
Ricardi, U1
Gontero, P1
Coyne, GO'1
Zlott, J1
Juwara, L1
Covey, JM1
Beumer, JH1
Cristea, MC1
Newman, EM1
Koehler, S1
Nieva, JJ1
Garcia, AA1
Gandara, DR1
Miller, B1
Khin, S1
Miller, SB1
Steinberg, SM1
Rubinstein, L1
Parchment, RE1
Kinders, RJ1
Piekarz, RL1
Kummar, S1
Chen, AP1
Doroshow, JH1
Gan, L1
Tian, Y3
Shi, B1
Li, G1
Wu, D1
Wen, A1
Koyappayil, A1
Chavan, SG1
Mohammadniaei, M1
Go, A1
Hwang, SY1
Lee, MH1
Kurokawa, Y1
Yamashita, K1
Kawabata, R1
Fujita, J1
Imamura, H1
Takeno, A1
Takahashi, T1
Yamasaki, M1
Eguchi, H1
Doki, Y1
Schulte, T1
Sala, BM1
Nilvebrant, J1
Nygren, PÅ1
Achour, A1
Shernyukov, A1
Agback, T1
Agback, P1
Karami, H1
Shariatifar, N1
Nazmara, S1
Moazzen, M1
Mahmoodi, B1
Mousavi Khaneghah, A1
Sinha, N1
Mukhopadhyay, S1
Sau, M1
Qi, Y1
Wan, M1
Abd El-Aty, AM1
Cao, L2
She, Y1
Shao, Y1
Jin, F1
Wang, S1
Melendez-Araújo, MS1
Lemos, KGE1
Arruda, SLM1
Dutra, ES1
de Carvalho, KMB1
de la Plaza Llamas, R1
Díaz Candelas, DA1
Ramia, JM1
Zhu, S1
Xiang, Z1
Lan, J1
Yu, M1
Sirajudeen, AAO1
Annuar, MSM1
Subramaniam, R1
Somme, F1
Montaz-Rosset, MS1
Averous, G1
Deur, J1
Goichot, B1
Bachellier, P1
Addeo, P1
Imperiale, A1
Song, S1
Mo, L1
Fan, W1
Tong, X1
Singh, A1
Chen, HC1
Chen, YF1
Lu, YJ1
Wong, KT1
Chu, CW1
Banijamali, AR1
Carvalho, AE1
Wakefield, JD1
Germano, P1
Barden, TC1
Tobin, JV1
Zimmer, DP1
Masferrer, JL1
Profy, AT1
Currie, MG1
Todd Milne, G1
Dang, Z1
Zhan, S1
Sun, C1
Hu, G1
Lin, Y2
Karayağiz Muslu, G1
Özdemir, M1
Del Prete, S1
Nocentini, A1
Supuran, CT1
Capasso, C1
Chagas, ATA1
Ludwig, S1
Pimentel, JDSM1
de Abreu, NL1
Nunez-Rodriguez, DL1
Leal, HG1
Kalapothakis, E1
Dodig, D1
Kovačić, S1
Matana Kaštelan, Z1
Žuža, I1
Benić, F1
Slaven, J1
Miletić, D1
Rumboldt, Z1
Fernandez-Botran, R1
Wellmann, IA1
Une, C1
Méndez-Chacón, E1
Hernández de Rodas, E1
Bhandari, B1
Villagrán de Tercero, CI1
Nguyen, HTT1
Romano, F1
Wampfler, R1
Mühlethaler, K1
Tannich, E1
Oberli, A1
Xiang, T1
Dai, L1
Zuo, D1
Sui, Y1
Zheng, H1
Qiu, C1
Jin, H1
Kerwin, J1
Khan, I1
Rajasekhar, B1
Venkateshwaran, U1
Durairaj, N1
Divyapriya, G1
Nambi, IM1
Joseph, A1
Aliste, M1
Garrido, I1
Flores, P1
Hellín, P1
Vela, N1
Navarro, S1
Fenoll, J1
Yumita, N1
Iwase, Y1
Umemura, SI1
Chen, FS1
Momose, Y1
Kim, OH1
Son, JI1
Kim, KY1
Lee, HJ2
Barna, BP6
Voronkova, MA1
Luanpitpong, S1
Rojanasakul, LW1
Castranova, V3
Dinu, CZ1
Riedel, H1
Rojanasakul, Y2
Duke, KS1
Mohan, A2
McPeek, M3
Schnapp, LM1
Gharib, SA1
Tokarz, DA1
Murray, G2
Kane, AB1
Hurt, RH1
Lee, SW2
Park, HJ1
Van Kaer, L1
Hong, S2
Guo, B1
Liang, Y1
Ma, PX1
Weng, W1
He, S1
Song, H1
Peng, H2
Su, J1
Javed, I1
Yu, T1
Peng, G1
Sánchez-Ferrer, A1
Faridi, A1
Kakinen, A1
Mezzenga, R1
Davis, TP1
Ke, PC2
Otsuka, K1
Yamada, K1
Taquahashi, Y1
Arakaki, R1
Ushio, A1
Saito, M1
Yamada, A1
Tsunematsu, T1
Kudo, Y1
Kanno, J1
Ishimaru, N1
Lee, DK1
Jeon, S1
Han, Y2
Kim, SH1
Lee, S1
Yu, IJ1
Song, KS1
Kang, A1
Yun, WS1
Kang, SM1
Huh, YS1
Cho, WS1
Kittana, N1
Assali, M1
Abu-Rass, H1
Lutz, S1
Hindawi, R1
Ghannam, L1
Zakarneh, M1
Mousa, A1
Barrington, RA1
Muller-Borer, B1
Kew, K1
Russell, J1
Jones, JL1
Wingard, CJ3
Oliveira, FC1
Carvalho, JO1
Gusmão, SBS1
Gonçalves, LS1
Soares Mendes, LM1
Freitas, SAP1
Gusmão, GOM1
Viana, BC1
Marciano, FR1
Lobo, AO1
Kasai, T3
Umeda, Y2
Sasaki, T1
Fukushima, S2
Pedrotty, DM1
Kuzmenko, V1
Karabulut, E1
Sugrue, AM1
Livia, C1
Vaidya, VR1
McLeod, CJ1
Asirvatham, SJ1
Gatenholm, P1
Kapa, S1
Ceppi, L1
Bardhan, NM1
Na, Y1
Siegel, A1
Rajan, N1
Fruscio, R1
Del Carmen, MG1
Belcher, AM1
Birrer, MJ1
Cole, E1
Ray, JL1
Bolten, S1
Hamilton, RF1
Shaw, PK1
Postma, B1
Buford, M1
Holian, A1
Cho, YH1
Wait, JM2
Tomita, H1
Burk, LM2
Zhou, OZ1
Maeda, N1
Lee, YZ2
Ronzani, C1
Casset, A1
Pons, F1
Nygaard, UC1
Samuelsen, M1
Marioara, CD1
Løvik, M1
Nagai, H1
Okazaki, Y1
Chew, SH1
Misawa, N1
Miyata, Y1
Shinohara, H1
Toyokuni, S1
Zhou, J1
Mou, Y1
Tang, R1
Zhong, W1
Mengqiu Xing, M1
Chen, T1
Nie, H1
Pu, J1
Cui, X1
Jia, G1
Walling, BE1
Lau, GW1
Chen, H2
Chang, Q1
Kwan, JK1
Yeung, KL1
Xi, Z1
Lu, Z1
Shi, H1
Yu, C1
Hao, C1
Du, J1
Diao, S1
Gong, H1
Hong, G1
Xue, X1
Wang, LR1
Sato, Y1
Berg, M1
Yang, DS1
Nixon, RA1
Liang, XJ1
Dymacek, J1
Snyder-Talkington, BN1
Porter, DW1
Wolfarth, MG1
Qian, Y1
Guo, NL1
Al Faraj, A2
Shaik, AP1
Shaik, AS2
Wang, KH1
Kang, E1
Willis, M1
Zhou, O1
Han, SG1
Howatt, D1
Daugherty, A1
Gairola, G1
Imani, S1
Zagari, Z1
Rezaei Zarchi, S1
Jorjani, M1
Nasri, S1
Shipkowski, KA1
Taylor, AJ1
Thompson, EA1
Glista-Baker, EE1
Sayers, BC1
Messenger, ZJ1
Bauer, RN1
Jaspers, I1
Nowacki, M1
Wisniewski, M1
Werengowska-Ciecwierz, K1
Roszek, K1
Czarnecka, J1
Łakomska, I1
Kloskowski, T1
Tyloch, D1
Debski, R1
Pietkun, K1
Pokrywczynska, M1
Grzanka, D1
Czajkowski, R1
Drewa, G1
Jundziłł, A1
Agyin, JK1
Habib, SL1
Terzyk, AP1
Drewa, T1
Frank, EA1
Birch, ME1
Yadav, JS1
Chen, A1
Xia, M1
Meng, G1
Kang, B1
Wei, J1
Halwani, R1
Alfuraih, A1
Fessler, MB1
Dobbs, L2
Verbanac, KM1
Bowling, M1
Judson, MA1
Ouyang, M1
White, EE1
Zhang, I1
Yanyan, S1
Weng, Y1
Da Fonseca, A1
Shah, S1
Manuel, ER1
Vonderfecht, SL1
Alizadeh, D3
Berlin, JM1
Badie, B3
Ding, S1
Bao, Y1
Pan, Y1
Wan, J1
Ji, J1
Liu, R1
Ye, C1
Calegari, LP1
Dias, RS1
de Oliveira, MD1
Pessoa, CR1
de Oliveira, AS1
Oliveira, AF1
da Silva, CC1
Fonseca, FG1
Versiani, AF1
De Paula, SO1
Hassanzadeh, P2
Arbabi, E2
Atyabi, F2
Dinarvand, R2
Marangon, I1
Silva, AA1
Guilbert, T1
Kolosnjaj-Tabi, J1
Marchiol, C1
Natkhunarajah, S1
Chamming's, F1
Ménard-Moyon, C1
Bianco, A1
Gennisson, JL1
Renault, G1
Gazeau, F1
Marei, HE1
Elnegiry, AA1
Zaghloul, A1
Althani, A1
Afifi, N1
Abd-Elmaksoud, A1
Farag, A1
Lashen, S1
Rezk, S1
Shouman, Z1
Cenciarelli, C1
Hasan, A1
Liu, F1
Wei, GF1
Liu, ZP1
Huang, R1
VanHandel, M1
Kateb, B1
Bronikowski, M1
Manohara, H1
Inoue, K1
Koike, E1
Yanagisawa, R1
Hirano, S1
Nishikawa, M1
Takano, H1
Mitchell, LA1
Lauer, FT1
Burchiel, SW1
McDonald, JD1
Qiu, A1
Scabilloni, JF1
Wu, N1
Donaldson, K1
Murphy, FA1
Duffin, R1
Poland, CA1
Aiso, S1
Yamazaki, K1
Asakura, M1
Takaya, M1
Toya, T1
Koda, S1
Nagano, K1
Arito, H1
Huang, N1
Lui, H1
Korbelik, M1
Zeng, H1
Matsumura, S1
Iizuka, T1
Shiba, K1
Kanamori, T1
Yudasaka, M1
Iijima, S1
Yokoyama, A1
Park, J1
Yoon, OJ1
Kim, HW1
Lee, DY1
Kim, DH1
Lee, WB1
Lee, NE1
Bonventre, JV1
Kim, SS1
Roman, JA1
Niedzielko, TL1
Haddon, RC1
Parpura, V2
Floyd, CL1
Dikensoy, O1
Bayram, H1
Huizar, I1
Midgette, YA1
Kukoly, C1
Chen, P1
Podila, R1
Rao, AM1
Kavuru, MS1
Jin, C1
Di, Y1
Ni, Q1
Fu, D1
Lee, GJ1
Choi, SK1
Choi, S1
Park, HK1
Jones, LP1
Stefansson, S1
Kim, MS1
Ahn, SN1
Mocan, T1
Iancu, C1
Kempen, P1
Bouley, D1
Xu, A1
Melosh, N1
Gambhir, SS1
Silva, GA1
Tass, PA1
Bennet, KE1
Meyyappan, M1
Koehne, J1
Lee, KH1
Andrews, RJ1
Møller, P1
Danielsen, PH1
Jantzen, K1
Roursgaard, M1
Loft, S1
Radomski, A1
Jurasz, P1
Alonso-Escolano, D1
Drews, M1
Morandi, M1
Malinski, T1
Radomski, MW1
Nemmar, A1
Hoet, PH1
Vandervoort, P1
Dinsdale, D1
Nemery, B1
Hoylaerts, MF1
Chou, CC1
Hsiao, HY1
Hong, QS1
Chen, CH1
Peng, YW1
Chen, HW1
Yang, PC1
György, S1
Choi, JB1
Choi, JY1
Kim, SG1
Leung, LY1
Larimore, Z1
Holmes, L1
Cartagena, C1
Mountney, A1
Deng-Bryant, Y1
Schmid, K1
Shear, D1
Tortella, F1
Dong, H1
Manning, BM1
Hebbel, RP1
Gupta, K1
Haynes, CL1
Keating, DJ1
Winter, MA1
Hemsley, KM1
Mackenzie, KD1
Teo, EH1
Hopwood, JJ1
Brooks, DA1
Parkinson-Lawrence, EJ1
Fang, Y1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Detection of Exhaled Methane Levels for the Recognition and Monitoring of Hemorrhagic Shock - Study Protocol for a Prospective Observational Study[NCT04987411]40 participants (Anticipated)Observational2021-11-01Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

15 reviews available for methane and Disease Models, Animal

ArticleYear
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
    Medicina clinica (English ed.), 2022, Dec-23, Volume: 159, Issue:12

    Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter

2022
    Computational & theoretical chemistry, 2013, Feb-01, Volume: 1005

    Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Am

2013
    Computational & theoretical chemistry, 2013, Feb-01, Volume: 1005

    Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Am

2013
    Computational & theoretical chemistry, 2013, Feb-01, Volume: 1005

    Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Am

2013
    Computational & theoretical chemistry, 2013, Feb-01, Volume: 1005

    Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Am

2013
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
Anticancer metal-N-heterocyclic carbene complexes of gold, platinum and palladium.
    Current opinion in chemical biology, 2018, Volume: 43

    Topics: Animals; Antineoplastic Agents; Disease Models, Animal; Gold; Heterocyclic Compounds; Humans; Ligand

2018
Nitromethane.
    IARC monographs on the evaluation of carcinogenic risks to humans, 2000, Volume: 77

    Topics: Animals; Carcinogenicity Tests; Carcinogens; Disease Models, Animal; Environmental Exposure; Female;

2000
Biochemical mechanisms of liver injury.
    The American journal of medicine, 1970, Volume: 49

    Topics: Aflatoxins; Alkaloids; Animals; Calcium; Carbon Tetrachloride Poisoning; Chloroform; Disease Models,

1970
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
    Science & sports, 2023, Apr-04

    Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp

2023
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
    Science & sports, 2023, Apr-04

    Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp

2023
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
    Science & sports, 2023, Apr-04

    Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp

2023
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
    Science & sports, 2023, Apr-04

    Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp

2023
Studies in a Murine Granuloma Model of Instilled Carbon Nanotubes: Relevance to Sarcoidosis.
    International journal of molecular sciences, 2021, Apr-02, Volume: 22, Issue:7

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 1; Disease Models, Animal; Granuloma;

2021
Mechanisms of carbon nanotube-induced pulmonary fibrosis: a physicochemical characteristic perspective.
    Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology, 2018, Volume: 10, Issue:3

    Topics: Animals; Cells, Cultured; Chemical Phenomena; Disease Models, Animal; Environmental Exposure; Epithe

2018
The asbestos-carbon nanotube analogy: An update.
    Toxicology and applied pharmacology, 2018, 12-15, Volume: 361

    Topics: Animals; Asbestos; Carcinogens; Disease Models, Animal; Humans; Lung Diseases; Nanostructures; Nanot

2018
Perturbation of pulmonary immune functions by carbon nanotubes and susceptibility to microbial infection.
    Journal of microbiology (Seoul, Korea), 2014, Volume: 52, Issue:3

    Topics: Animals; Disease Models, Animal; Disease Susceptibility; Lung; Mice; Nanotubes, Carbon; Occupational

2014
Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma.
    Particle and fibre toxicology, 2010, Mar-22, Volume: 7

    Topics: Air Pollutants; Animals; Asbestos; Disease Models, Animal; Epithelium; Humans; Mesothelioma; Metabol

2010
The current data on nanoparticles and pleura.
    Tuberkuloz ve toraks, 2010, Volume: 58, Issue:4

    Topics: Animals; Disease Models, Animal; Humans; Mesothelioma; Nanoparticles; Nanotubes, Carbon; Particle Si

2010
Neuromodulation: selected approaches and challenges.
    Journal of neurochemistry, 2013, Volume: 124, Issue:4

    Topics: Animals; Brain; Brain Diseases; Deep Brain Stimulation; Disease Models, Animal; Humans; Models, Neur

2013
Oxidatively damaged DNA in animals exposed to particles.
    Critical reviews in toxicology, 2013, Volume: 43, Issue:2

    Topics: Animals; Asbestos; Cell Survival; Disease Models, Animal; DNA; DNA Damage; Dose-Response Relationshi

2013

Trials

5 trials available for methane and Disease Models, Animal

ArticleYear
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
    Medicina clinica (English ed.), 2022, Dec-23, Volume: 159, Issue:12

    Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter

2022
    Computational & theoretical chemistry, 2013, Feb-01, Volume: 1005

    Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Am

2013
    Computational & theoretical chemistry, 2013, Feb-01, Volume: 1005

    Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Am

2013
    Computational & theoretical chemistry, 2013, Feb-01, Volume: 1005

    Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Am

2013
    Computational & theoretical chemistry, 2013, Feb-01, Volume: 1005

    Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Am

2013
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
    Science & sports, 2023, Apr-04

    Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp

2023
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
    Science & sports, 2023, Apr-04

    Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp

2023
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
    Science & sports, 2023, Apr-04

    Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp

2023
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
    Science & sports, 2023, Apr-04

    Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp

2023
    Angewandte Chemie (Weinheim an der Bergstrasse, Germany), 2007, Aug-27, Volume: 119, Issue:34

    Topics: 3-Hydroxybutyric Acid; Acetazolamide; Acrylates; Administration, Intravenous; Adolescent; Adult; Aer

2007

Other Studies

109 other studies available for methane and Disease Models, Animal

ArticleYear
Methane Alleviates Inflammation and Apoptosis of Dextran Sulfate Sodium-Induced Inflammatory Bowel Diseases by Inhibiting Toll-Like Receptor 4 (TLR4)/Myeloid Differentiation Factor 88 (MyD88)/Nuclear Translocation of Nuclear Factor-κB (NF-κB) and Endoplas
    Medical science monitor : international medical journal of experimental and clinical research, 2020, Jun-05, Volume: 26

    Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Dextran Sulfate; Disease Models, Animal; Endoplasmic R

2020
Methane rescues retinal ganglion cells and limits retinal mitochondrial dysfunction following optic nerve crush.
    Experimental eye research, 2017, Volume: 159

    Topics: Animals; Apoptosis; Axons; Disease Models, Animal; Male; Methane; Mitochondria; Optic Nerve; Optic N

2017
Methane Suppresses Microglial Activation Related to Oxidative, Inflammatory, and Apoptotic Injury during Spinal Cord Injury in Rats.
    Oxidative medicine and cellular longevity, 2017, Volume: 2017

    Topics: Animals; Apoptosis; Disease Models, Animal; Female; Inflammation; Methane; Microglia; Oxidative Stre

2017
Analgesic Effect of Methane Rich Saline in a Rat Model of Chronic Inflammatory Pain.
    Neurochemical research, 2018, Volume: 43, Issue:4

    Topics: Analgesics; Animals; Chronic Pain; Disease Models, Animal; Inflammation; Inflammation Mediators; Mal

2018
Inhaled Methane Protects Rats Against Neurological Dysfunction Induced by Cerebral Ischemia and Reperfusion Injury: PI3K/Akt/HO-1 Pathway Involved.
    Archives of medical research, 2017, Volume: 48, Issue:6

    Topics: Analysis of Variance; Animals; Antioxidants; Biomarkers; Brain Diseases; Brain Ischemia; Chromones;

2017
Reduction of nitrosative stress by methane: Neuroprotection through xanthine oxidoreductase inhibition in a rat model of mesenteric ischemia-reperfusion.
    Free radical biology & medicine, 2018, 05-20, Volume: 120

    Topics: Animals; Disease Models, Animal; Male; Mesenteric Ischemia; Methane; Myenteric Plexus; Neuroprotecti

2018
Protective Effects of Methane-Rich Saline on Renal Ischemic-Reperfusion Injury in a Mouse Model.
    Medical science monitor : international medical journal of experimental and clinical research, 2018, Oct-31, Volume: 24

    Topics: Acute Kidney Injury; Animals; Apoptosis; Blood Urea Nitrogen; Creatinine; Disease Models, Animal; In

2018
Methane inhalation reduces the systemic inflammatory response in a large animal model of extracorporeal circulation.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2019, Jul-01, Volume: 56, Issue:1

    Topics: Administration, Inhalation; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Extracorporea

2019
Methane ameliorates post-operative cognitive dysfunction by inhibiting microglia NF-κB/MAPKs pathway and promoting IL-10 expression in aged mice.
    International immunopharmacology, 2019, Volume: 71

    Topics: Aging; Animals; Behavior, Animal; Cells, Cultured; Cognitive Dysfunction; Disease Models, Animal; Ex

2019
Detection of Intestinal Tissue Perfusion by Real-Time Breath Methane Analysis in Rat and Pig Models of Mesenteric Circulatory Distress.
    Critical care medicine, 2019, Volume: 47, Issue:5

    Topics: Animals; Breath Tests; Disease Models, Animal; Hemodynamics; Male; Mesenteric Ischemia; Methane; Rat

2019
Indolylkojyl methane analogue IKM5 potentially inhibits invasion of breast cancer cells via attenuation of GRP78.
    Breast cancer research and treatment, 2019, Volume: 177, Issue:2

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival;

2019
Determination of endogenous methane formation by photoacoustic spectroscopy.
    Journal of breath research, 2013, Volume: 7, Issue:4

    Topics: Animals; Breath Tests; Chromatography, Gas; Cross-Sectional Studies; Disease Models, Animal; Female;

2013
Gold (I) N-heterocyclic carbene complex inhibits mouse melanoma growth by p53 upregulation.
    Molecular cancer, 2014, Mar-13, Volume: 13

    Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Disease Models, Anim

2014
Neuroprotective effects of exogenous methane in a rat model of acute carbon monoxide poisoning.
    Brain research, 2016, Feb-15, Volume: 1633

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Blotting, Western; Brain; Carbon Monoxid

2016
Neuroprotective effects of methane-rich saline on experimental acute carbon monoxide toxicity.
    Journal of the neurological sciences, 2016, Oct-15, Volume: 369

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Analysis of Variance; Animals; Carbon Monoxide Poisoning; Carboxyhemogl

2016
Inhalation of methane preserves the epithelial barrier during ischemia and reperfusion in the rat small intestine.
    Surgery, 2017, Volume: 161, Issue:6

    Topics: Administration, Inhalation; Animals; Capillary Permeability; Disease Models, Animal; Endothelin-1; I

2017
In vitro and murine efficacy and toxicity studies of nebulized SCC1, a methylated caffeine-silver(I) complex, for treatment of pulmonary infections.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Caffeine; Cell Line; Disease Models, Animal; Male; Methane; Methylat

2009
A theobromine derived silver N-heterocyclic carbene: synthesis, characterization, and antimicrobial efficacy studies on cystic fibrosis relevant pathogens.
    Dalton transactions (Cambridge, England : 2003), 2009, Sep-21, Issue:35

    Topics: Animals; Anti-Bacterial Agents; Crystallography, X-Ray; Cystic Fibrosis; Disease Models, Animal; Dos

2009
In vivo activity of thiophene-containing trisubstituted methanes against acute and persistent infection of non-tubercular Mycobacterium fortuitum in a murine infection model.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Cell Survival; Chlorocebus aethiops; Disease Models, Animal; Female;

2012
[Characterization of the antiinflammatory properties of methane inhalation during ischaemia-reperfusion].
    Magyar sebeszet, 2012, Volume: 65, Issue:4

    Topics: Administration, Inhalation; Animals; Anti-Inflammatory Agents; Biomarkers; Carbon Dioxide; Disease M

2012
Relaxant properties mediated by nitroglycerin in aortic coarctation hypertensive rats.
    Heart and vessels, 2002, Volume: 17, Issue:2

    Topics: Animals; Aorta, Abdominal; Aorta, Thoracic; Aortic Coarctation; Blood Pressure; Charybdotoxin; Disea

2002
Macrophage ablation attenuates adenoviral vector-induced pancreatitis.
    Surgery, 2005, Volume: 137, Issue:5

    Topics: Acute Disease; Adenoviridae; Animals; Diphosphonates; Disease Models, Animal; Female; Genetic Vector

2005
The hepatic vagus nerve attenuates Fas-induced apoptosis in the mouse liver via alpha7 nicotinic acetylcholine receptor.
    Gastroenterology, 2008, Volume: 134, Issue:7

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Mu

2008
Serotonin in experimental histidinemia.
    Neurochemical research, 1980, Volume: 5, Issue:8

    Topics: Amino Acid Metabolism, Inborn Errors; Animals; Body Weight; Brain; Disease Models, Animal; Histidine

1980
Toxicity of aerosol propellants in the respiratory and circularoty systems. X. Proposed classification.
    Toxicology, 1975, Volume: 3, Issue:3

    Topics: Adrenal Medulla; Aerosol Propellants; Aerosols; Animals; Arrhythmias, Cardiac; Blood Pressure; Bronc

1975
Methylene chloride and chronic renal hypertension.
    Archives of pathology, 1973, Volume: 95, Issue:2

    Topics: Animals; Blood Pressure; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Hydrocarbon

1973
Carbon-nanotube yarns induce axonal regeneration in peripheral nerve defect.
    Scientific reports, 2021, 10-01, Volume: 11, Issue:1

    Topics: Animals; Disease Models, Animal; Electrophysiological Phenomena; Female; Immunohistochemistry; Muscl

2021
Histopathology of the broad class of carbon nanotubes and nanofibers used or produced in U.S. facilities in a murine model.
    Particle and fibre toxicology, 2021, 12-20, Volume: 18, Issue:1

    Topics: Animals; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Nanofibers; Nanotubes, Carbon; Pulm

2021
Myeloid ABCG1 Deficiency Enhances Apoptosis and Initiates Efferocytosis in Bronchoalveolar Lavage Cells of Murine Multi-Walled Carbon Nanotube-Induced Granuloma Model.
    International journal of molecular sciences, 2021, Dec-21, Volume: 23, Issue:1

    Topics: Animals; Apoptosis; ATP Binding Cassette Transporter, Subfamily G, Member 1; Bronchoalveolar Lavage;

2021
Gram-scale preparation of quercetin supramolecular nanoribbons for intestinal inflammatory diseases by oral administration.
    Biomaterials, 2023, Volume: 295

    Topics: Administration, Oral; Animals; Antioxidants; Colitis; Disease Models, Animal; Intestinal Mucosa; Nan

2023
Role of the protease-activated receptor-2 (PAR2) in the exacerbation of house dust mite-induced murine allergic lung disease by multi-walled carbon nanotubes.
    Particle and fibre toxicology, 2023, 08-14, Volume: 20, Issue:1

    Topics: Allergens; Animals; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Fibrosis; Hypersensitivity

2023
In Vivo Restoration of Myocardial Conduction With Carbon Nanotube Fibers.
    Circulation. Arrhythmia and electrophysiology, 2019, Volume: 12, Issue:8

    Topics: Animals; Arrhythmias, Cardiac; Atrioventricular Node; Carbon Fiber; Catheter Ablation; Disease Model

2019
Multi-walled carbon nanotubes activate and shift polarization of pulmonary macrophages and dendritic cells in an
    Nanotoxicology, 2020, Volume: 14, Issue:1

    Topics: Animals; Bronchoalveolar Lavage Fluid; Dendritic Cells; Disease Models, Animal; Female; Inhalation E

2020
Balanced Th1/Th2 immune response induced by MSP1a functional motif coupled to multiwalled carbon nanotubes as anti-anaplasmosis vaccine in murine model.
    Nanomedicine : nanotechnology, biology, and medicine, 2020, Volume: 24

    Topics: Anaplasma; Anaplasmosis; Animals; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Cell Survi

2020
Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis.
    Nature nanotechnology, 2020, Volume: 15, Issue:2

    Topics: Animals; Atherosclerosis; Cardiovascular Agents; CD47 Antigen; Disease Models, Animal; Female; Macro

2020
Immobilization of novel inorganic nano-complexes onto MWCNT nanomaterials as a novel adsorbent and anti-inflammatory therapy in an induced model of rheumatoid arthritis.
    Nanotechnology, 2020, Jul-24, Volume: 31, Issue:30

    Topics: Adsorption; Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Azo Compounds; Cobalt; Disease

2020
Sonodynamically-induced Anticancer Effects of Polyethylene Glycol-Modified Carbon Nano Tubes.
    Anticancer research, 2020, Volume: 40, Issue:5

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Disease Models, Animal; Humans; Male; Mice; Molecu

2020
Both Intracranial and Intravenous Administration of Functionalized Carbon Nanotubes Protect Dopaminergic Neuronal Death from 6-Hydroxydopamine.
    International journal of nanomedicine, 2020, Volume: 15

    Topics: Administration, Intravenous; Animals; Antioxidants; Behavior, Animal; Cell Death; Cell Differentiati

2020
SOX9 Regulates Cancer Stem-Like Properties and Metastatic Potential of Single-Walled Carbon Nanotube-Exposed Cells.
    Scientific reports, 2017, 09-14, Volume: 7, Issue:1

    Topics: Animals; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Transformation, Neoplastic; Diseas

2017
Transcriptional survey of alveolar macrophages in a murine model of chronic granulomatous inflammation reveals common themes with human sarcoidosis.
    American journal of physiology. Lung cellular and molecular physiology, 2018, 04-01, Volume: 314, Issue:4

    Topics: Animals; Case-Control Studies; Disease Models, Animal; Female; Gene Expression Profiling; Gene Expre

2018
PPAR-gamma pathways attenuate pulmonary granuloma formation in a carbon nanotube induced murine model of sarcoidosis.
    Biochemical and biophysical research communications, 2018, 09-05, Volume: 503, Issue:2

    Topics: Animals; Disease Models, Animal; Dyslipidemias; Gene Expression Regulation; Granuloma; Lung; Lung Di

2018
Graphene oxide polarizes iNKT cells for production of TGFβ and attenuates inflammation in an iNKT cell-mediated sepsis model.
    Scientific reports, 2018, 07-04, Volume: 8, Issue:1

    Topics: Animals; Antigens, CD1d; Cell Polarity; Dendritic Cells; Disease Models, Animal; Galactosylceramides

2018
Injectable antibacterial conductive nanocomposite cryogels with rapid shape recovery for noncompressible hemorrhage and wound healing.
    Nature communications, 2018, 07-17, Volume: 9, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Bandages; Chitosan; Cryogels; Disease Models, Animal; Epoxy Compound

2018
Aligned Carbon Nanotubes Reduce Hypertrophic Scar via Regulating Cell Behavior.
    ACS nano, 2018, 08-28, Volume: 12, Issue:8

    Topics: Animals; Cell Proliferation; Cicatrix, Hypertrophic; Disease Models, Animal; Ear Diseases; Humans; M

2018
In Vivo Mitigation of Amyloidogenesis through Functional-Pathogenic Double-Protein Coronae.
    Nano letters, 2018, 09-12, Volume: 18, Issue:9

    Topics: Amyloid; Animals; Disease Models, Animal; Humans; Islet Amyloid Polypeptide; Lactoglobulins; Nanotub

2018
Long-term polarization of alveolar macrophages to a profibrotic phenotype after inhalation exposure to multi-wall carbon nanotubes.
    PloS one, 2018, Volume: 13, Issue:10

    Topics: Air Pollutants; Air Pollution; Animals; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Female

2018
Threshold Rigidity Values for the Asbestos-like Pathogenicity of High-Aspect-Ratio Carbon Nanotubes in a Mouse Pleural Inflammation Model.
    ACS nano, 2018, 11-27, Volume: 12, Issue:11

    Topics: Animals; Asbestos; Disease Models, Animal; Female; Humans; Inflammation; Mice; Mice, Inbred ICR; Nan

2018
Enhancement of wound healing by single-wall/multi-wall carbon nanotubes complexed with chitosan.
    International journal of nanomedicine, 2018, Volume: 13

    Topics: Animals; Chitosan; Collagen; Connective Tissue; Disease Models, Animal; Extracellular Matrix; Fibrob

2018
Peroxisome Proliferator-activated Receptor-γ Deficiency Exacerbates Fibrotic Response to Mycobacteria Peptide in Murine Sarcoidosis Model.
    American journal of respiratory cell and molecular biology, 2019, Volume: 61, Issue:2

    Topics: Animals; Antigens, Bacterial; Bacterial Proteins; Bronchoalveolar Lavage; Bronchoalveolar Lavage Flu

2019
High loads of nano-hydroxyapatite/graphene nanoribbon composites guided bone regeneration using an osteoporotic animal model.
    International journal of nanomedicine, 2019, Volume: 14

    Topics: Alkaline Phosphatase; Animals; Bone Regeneration; Disease Models, Animal; Durapatite; Female; Graphi

2019
Thinking on occupational exposure assessment of multi-walled carbon nanotube carcinogenicity.
    Journal of occupational health, 2019, Volume: 61, Issue:2

    Topics: Adenocarcinoma, Bronchiolo-Alveolar; Animals; Disease Models, Animal; Dose-Response Relationship, Dr

2019
Three-Dimensional Printed Biopatches With Conductive Ink Facilitate Cardiac Conduction When Applied to Disrupted Myocardium.
    Circulation. Arrhythmia and electrophysiology, 2019, Volume: 12, Issue:3

    Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Biocompatible Materials; Cellulose; Disease Models

2019
Real-Time Single-Walled Carbon Nanotube-Based Fluorescence Imaging Improves Survival after Debulking Surgery in an Ovarian Cancer Model.
    ACS nano, 2019, 05-28, Volume: 13, Issue:5

    Topics: Animals; Bacteriophage M13; Cell Line, Tumor; Contrast Media; Cytoreduction Surgical Procedures; Dis

2019
Multiwalled Carbon Nanotubes of Varying Size Lead to DNA Methylation Changes That Correspond to Lung Inflammation and Injury in a Mouse Model.
    Chemical research in toxicology, 2019, 08-19, Volume: 32, Issue:8

    Topics: Animals; Cytokines; Disease Models, Animal; DNA; DNA Methylation; Female; Lung Injury; Male; Mice; M

2019
Detection of aortic arch calcification in apolipoprotein E-null mice using carbon nanotube-based micro-CT system.
    Journal of the American Heart Association, 2013, Feb-22, Volume: 2, Issue:1

    Topics: Animals; Aorta, Thoracic; Aortic Diseases; Aortography; Apolipoproteins E; Atherosclerosis; Disease

2013
Exposure to multi-walled carbon nanotubes results in aggravation of airway inflammation and remodeling and in increased production of epithelium-derived innate cytokines in a mouse model of asthma.
    Archives of toxicology, 2014, Volume: 88, Issue:2

    Topics: Airway Remodeling; Allergens; Animals; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Disease Mode

2014
Carbon nanofibers have IgE adjuvant capacity but are less potent than nanotubes in promoting allergic airway responses.
    BioMed research international, 2013, Volume: 2013

    Topics: Adjuvants, Immunologic; Animals; Carbon; Disease Models, Animal; Hypersensitivity; Immunoglobulin E;

2013
Intraperitoneal administration of tangled multiwalled carbon nanotubes of 15 nm in diameter does not induce mesothelial carcinogenesis in rats.
    Pathology international, 2013, Volume: 63, Issue:9

    Topics: Animals; Asbestos; Cell Transformation, Neoplastic; Disease Models, Animal; Environmental Health; Fe

2013
Engineering the heart: evaluation of conductive nanomaterials for improving implant integration and cardiac function.
    Scientific reports, 2014, Jan-16, Volume: 4

    Topics: Animals; Biocompatible Materials; Disease Models, Animal; Gelatin; Heart; Hydrogel, Polyethylene Gly

2014
Epithelial-mesenchymal transition involved in pulmonary fibrosis induced by multi-walled carbon nanotubes via TGF-beta/Smad signaling pathway.
    Toxicology letters, 2014, Apr-21, Volume: 226, Issue:2

    Topics: Actins; Animals; Antigens, CD; Biomarkers; Cadherins; Cell Line, Tumor; Collagen; Disease Models, An

2014
Application of vitamin E to antagonize SWCNTs-induced exacerbation of allergic asthma.
    Scientific reports, 2014, Mar-04, Volume: 4

    Topics: Animals; Asthma; Cytokines; Disease Models, Animal; Disease Progression; Immunoglobulin E; Immunoglo

2014
Prostate stem cell antigen antibody-conjugated multiwalled carbon nanotubes for targeted ultrasound imaging and drug delivery.
    Biomaterials, 2014, Volume: 35, Issue:20

    Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Antineoplastic Agents; Cell Line, Tumor; Diagno

2014
Tumor metastasis inhibition by imaging-guided photothermal therapy with single-walled carbon nanotubes.
    Advanced materials (Deerfield Beach, Fla.), 2014, Aug-27, Volume: 26, Issue:32

    Topics: Animals; Cell Line, Tumor; Combined Modality Therapy; Disease Models, Animal; Female; Hyperthermia,

2014
Single-walled carbon nanotubes alleviate autophagic/lysosomal defects in primary glia from a mouse model of Alzheimer's disease.
    Nano letters, 2014, Sep-10, Volume: 14, Issue:9

    Topics: Alzheimer Disease; Animals; Autophagy; Biocompatible Materials; Disease Models, Animal; Disease Prog

2014
mRNA and miRNA regulatory networks reflective of multi-walled carbon nanotube-induced lung inflammatory and fibrotic pathologies in mice.
    Toxicological sciences : an official journal of the Society of Toxicology, 2015, Volume: 144, Issue:1

    Topics: Animals; Computational Biology; Databases, Genetic; Disease Models, Animal; Gene Expression Profilin

2015
Magnetic single-walled carbon nanotubes as efficient drug delivery nanocarriers in breast cancer murine model: noninvasive monitoring using diffusion-weighted magnetic resonance imaging as sensitive imaging biomarker.
    International journal of nanomedicine, 2015, Volume: 10

    Topics: Animals; Apoptosis; Biomarkers; Breast Neoplasms; Cell Line, Tumor; Disease Models, Animal; DNA Dama

2015
Delayed contrast enhancement imaging of a murine model for ischemia reperfusion with carbon nanotube micro-CT.
    PloS one, 2015, Volume: 10, Issue:1

    Topics: Animals; Contrast Media; Diagnostic Imaging; Disease Models, Animal; Humans; Imaging, Three-Dimensio

2015
Pulmonary and atherogenic effects of multi-walled carbon nanotubes (MWCNT) in apolipoprotein-E-deficient mice.
    Journal of toxicology and environmental health. Part A, 2015, Volume: 78, Issue:4

    Topics: Animals; Apolipoproteins E; Atherosclerosis; Bronchoalveolar Lavage Fluid; Cardiovascular System; Ch

2015
Functional Recovery of Carbon Nanotube/Nafion Nanocomposite in Rat Model of Spinal Cord Injury.
    Artificial cells, nanomedicine, and biotechnology, 2016, Volume: 44, Issue:1

    Topics: Animals; Axons; Disease Models, Animal; Female; Fluorocarbon Polymers; Gait; Hyperalgesia; Nanocompo

2016
An Allergic Lung Microenvironment Suppresses Carbon Nanotube-Induced Inflammasome Activation via STAT6-Dependent Inhibition of Caspase-1.
    PloS one, 2015, Volume: 10, Issue:6

    Topics: Animals; Antigens, Dermatophagoides; Caspase 1; Cell Line; Chemotaxis, Leukocyte; Cytokines; Disease

2015
Nanovehicles as a novel target strategy for hyperthermic intraperitoneal chemotherapy: a multidisciplinary study of peritoneal carcinomatosis.
    Oncotarget, 2015, Sep-08, Volume: 6, Issue:26

    Topics: AC133 Antigen; Animals; Antibodies; Antigens, CD; Cisplatin; Combined Modality Therapy; Disease Mode

2015
MyD88 mediates in vivo effector functions of alveolar macrophages in acute lung inflammatory responses to carbon nanotube exposure.
    Toxicology and applied pharmacology, 2015, Nov-01, Volume: 288, Issue:3

    Topics: Acute Disease; Animals; Calcium; Cells, Cultured; Chemical Phenomena; Disease Models, Animal; Interl

2015
Photoacoustic "nanobombs" fight against undesirable vesicular compartmentalization of anticancer drugs.
    Scientific reports, 2015, Oct-20, Volume: 5

    Topics: Animals; Antineoplastic Agents; Biological Transport; Disease Models, Animal; Doxorubicin; Drug Carr

2015
Magnetic Targeting and Delivery of Drug-Loaded SWCNTs Theranostic Nanoprobes to Lung Metastasis in Breast Cancer Animal Model: Noninvasive Monitoring Using Magnetic Resonance Imaging.
    Molecular imaging and biology, 2016, Volume: 18, Issue:3

    Topics: Animals; Disease Models, Animal; Doxorubicin; Drug Delivery Systems; Female; Luminescent Measurement

2016
Elevated MicroRNA-33 in Sarcoidosis and a Carbon Nanotube Model of Chronic Granulomatous Disease.
    American journal of respiratory cell and molecular biology, 2016, Volume: 54, Issue:6

    Topics: Animals; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G, Member 1

2016
Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma Model.
    PloS one, 2016, Volume: 11, Issue:2

    Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Death; Cell Line, Tumor; Dacarbazine; Disease

2016
Neuroprotective effect of functionalized multi-walled carbon nanotubes on spinal cord injury in rats.
    International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:12

    Topics: Animals; Brain-Derived Neurotrophic Factor; Cells, Cultured; Cerebral Cortex; Disease Models, Animal

2015
Experimental Study of Magnetic Multi-Walled Carbon Nanotube-Doxorubicin Conjugate in a Lymph Node Metastatic Model of Breast Cancer.
    Medical science monitor : international medical journal of experimental and clinical research, 2016, Jul-07, Volume: 22

    Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Disease Models, Animal; Doxorubicin; Drug Delivery

2016
Multi-walled carbon nanotubes increase antibody-producing B cells in mice immunized with a tetravalent vaccine candidate for dengue virus.
    Journal of nanobiotechnology, 2016, Jul-27, Volume: 14, Issue:1

    Topics: Animals; Antibodies, Viral; B-Lymphocytes; Chlorocebus aethiops; Dengue; Dengue Vaccines; Dengue Vir

2016
Application of carbon nanotubes as the carriers of the cannabinoid, 2-arachidonoylglycerol: Towards a novel treatment strategy in colitis.
    Life sciences, 2017, Jun-15, Volume: 179

    Topics: Animals; Arachidonic Acids; Cannabinoid Receptor Agonists; Colitis; Disease Models, Animal; Drug Del

2017
Nerve growth factor-carbon nanotube complex exerts prolonged protective effects in an in vitro model of ischemic stroke.
    Life sciences, 2017, Jun-15, Volume: 179

    Topics: Animals; Brain Ischemia; Catalase; Cell Survival; Disease Models, Animal; Dose-Response Relationship

2017
Tumor Stiffening, a Key Determinant of Tumor Progression, is Reversed by Nanomaterial-Induced Photothermal Therapy.
    Theranostics, 2017, Volume: 7, Issue:2

    Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Disease Models, Animal; Elasticity Imaging

2017
Nanotubes impregnated human olfactory bulb neural stem cells promote neuronal differentiation in Trimethyltin-induced neurodegeneration rat model.
    Journal of cellular physiology, 2017, Volume: 232, Issue:12

    Topics: Animals; Behavior, Animal; Cells, Cultured; Cognition; Disease Models, Animal; Green Fluorescent Pro

2017
Engineering Carbon Nanotube Fiber for Real-Time Quantification of Ascorbic Acid Levels in a Live Rat Model of Alzheimer's Disease.
    Analytical chemistry, 2017, 02-07, Volume: 89, Issue:3

    Topics: Alzheimer Disease; Animals; Ascorbic Acid; Biosensing Techniques; Brain; Cerebral Cortex; Corpus Str

2017
Selective uptake of multi-walled carbon nanotubes by tumor macrophages in a murine glioma model.
    Journal of neuroimmunology, 2009, Mar-31, Volume: 208, Issue:1-2

    Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Drug Delivery Systems; Female; G

2009
Effects of multi-walled carbon nanotubes on a murine allergic airway inflammation model.
    Toxicology and applied pharmacology, 2009, Jun-15, Volume: 237, Issue:3

    Topics: Allergens; Animals; Antigen-Presenting Cells; Asthma; Cell Differentiation; Disease Models, Animal;

2009
Mechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in mice.
    Nature nanotechnology, 2009, Volume: 4, Issue:7

    Topics: Animals; Bronchoalveolar Lavage Fluid; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase Inhibito

2009
Direct fibrogenic effects of dispersed single-walled carbon nanotubes on human lung fibroblasts.
    Journal of toxicology and environmental health. Part A, 2010, Volume: 73, Issue:5

    Topics: Animals; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Fibroblasts; Humans; Lung; Mat

2010
Carbon nanotube uptake and toxicity in the brain.
    Methods in molecular biology (Clifton, N.J.), 2010, Volume: 625

    Topics: Animals; Biocompatible Materials; Brain; Cell Line; Disease Models, Animal; Female; Mice; Mice, Inbr

2010
Pulmonary toxicity of intratracheally instilled multiwall carbon nanotubes in male Fischer 344 rats.
    Industrial health, 2010, Volume: 48, Issue:6

    Topics: Albumins; Alveolar Epithelial Cells; Animals; Body Weight; Bronchoalveolar Lavage Fluid; Disease Mod

2010
Single-wall carbon nanotubes assisted photothermal cancer therapy: animal study with a murine model of squamous cell carcinoma.
    Lasers in surgery and medicine, 2010, Volume: 42, Issue:9

    Topics: Animals; Carcinoma, Squamous Cell; Disease Models, Animal; Hyperthermia, Induced; Injections, Intral

2010
Carbon nanohorns accelerate bone regeneration in rat calvarial bone defect.
    Nanotechnology, 2011, Feb-11, Volume: 22, Issue:6

    Topics: Animals; Bone Diseases; Bone Regeneration; Disease Models, Animal; Guided Tissue Regeneration; Histo

2011
Amine-modified single-walled carbon nanotubes protect neurons from injury in a rat stroke model.
    Nature nanotechnology, 2011, Volume: 6, Issue:2

    Topics: Amines; Animals; Cadherins; Disease Models, Animal; Glial Fibrillary Acidic Protein; Immunohistochem

2011
Single-walled carbon nanotubes chemically functionalized with polyethylene glycol promote tissue repair in a rat model of spinal cord injury.
    Journal of neurotrauma, 2011, Volume: 28, Issue:11

    Topics: Animals; Disease Models, Animal; Female; Nanotubes, Carbon; Polyethylene Glycols; Rats; Rats, Spragu

2011
Novel murine model of chronic granulomatous lung inflammation elicited by carbon nanotubes.
    American journal of respiratory cell and molecular biology, 2011, Volume: 45, Issue:4

    Topics: Animals; Bronchoalveolar Lavage Fluid; Cell Adhesion Molecules; Cytokines; Disease Models, Animal; G

2011
Magnetic functionalised carbon nanotubes as drug vehicles for cancer lymph node metastasis treatment.
    European journal of cancer (Oxford, England : 1990), 2011, Volume: 47, Issue:12

    Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Cell Survi

2011
Enzyme-immobilized CNT network probe for in vivo neurotransmitter detection.
    Methods in molecular biology (Clifton, N.J.), 2011, Volume: 743

    Topics: Amino Acid Oxidoreductases; Animals; Biosensing Techniques; Brain; Disease Models, Animal; Electroen

2011
Comparison of radioimmuno and carbon nanotube field-effect transistor assays for measuring insulin-like growth factor-1 in a preclinical model of human breast cancer.
    Journal of nanobiotechnology, 2011, Sep-02, Volume: 9

    Topics: Animals; Biomarkers, Tumor; Breast Neoplasms; Disease Models, Animal; Female; Genes, BRCA1; Humans;

2011
Effective colon cancer prophylaxis in mice using embryonic stem cells and carbon nanotubes.
    International journal of nanomedicine, 2011, Volume: 6

    Topics: Animals; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Division; Colonic Neoplasms; Cytokines; D

2011
Shape matters: intravital microscopy reveals surprising geometrical dependence for nanoparticles in tumor models of extravasation.
    Nano letters, 2012, Jul-11, Volume: 12, Issue:7

    Topics: Animals; Disease Models, Animal; Ear Neoplasms; Humans; Mice; Microscopy, Fluorescence; Nanoparticle

2012
Nanoparticle-induced platelet aggregation and vascular thrombosis.
    British journal of pharmacology, 2005, Volume: 146, Issue:6

    Topics: Animals; Blood Platelets; Carotid Artery Thrombosis; Chlorides; Disease Models, Animal; Dose-Respons

2005
Enhanced peripheral thrombogenicity after lung inflammation is mediated by platelet-leukocyte activation: role of P-selectin.
    Journal of thrombosis and haemostasis : JTH, 2007, Volume: 5, Issue:6

    Topics: Animals; Blood Platelets; Disease Models, Animal; Female; Granulocytes; Leukocytes; Male; Mice; Nano

2007
Single-walled carbon nanotubes can induce pulmonary injury in mouse model.
    Nano letters, 2008, Volume: 8, Issue:2

    Topics: Animals; Cells, Cultured; Cytokines; Disease Models, Animal; Lung; Lung Diseases; Macrophages; Male;

2008
Carbon plate shows even distribution of stress, decreases screw loosening, and increases recovery of preoperative daily feed intake amount in a rabbit model of mandibular continuity defects.
    Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2014, Volume: 42, Issue:5

    Topics: Animals; Biocompatible Materials; Biomechanical Phenomena; Bone Plates; Bone Screws; Carbon; Carbon

2014
The WRAIR projectile concussive impact model of mild traumatic brain injury: re-design, testing and preclinical validation.
    Annals of biomedical engineering, 2014, Volume: 42, Issue:8

    Topics: Amyloid beta-Peptides; Animals; Axons; Biomechanical Phenomena; Brain; Brain Concussion; Brain Injur

2014
Label-Free Electrochemical Biosensor for Monitoring of Chloride Ion in an Animal Model of Alzhemier's Disease.
    ACS chemical neuroscience, 2017, 02-15, Volume: 8, Issue:2

    Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Biosensing Techniques; Brain; Brain Isch

2017
Carbon-fiber microelectrode amperometry reveals sickle-cell-induced inflammation and chronic morphine effects on single mast cells.
    ACS chemical biology, 2012, Mar-16, Volume: 7, Issue:3

    Topics: 3T3-L1 Cells; Anemia, Sickle Cell; Animals; Carbon; Carbon Fiber; Cells, Cultured; Disease Models, A

2012
Exocytosis is impaired in mucopolysaccharidosis IIIA mouse chromaffin cells.
    Neuroscience, 2012, Dec-27, Volume: 227

    Topics: Adrenal Glands; Analysis of Variance; Animals; Calcium; Carbon; Carbon Fiber; Catecholamines; Cells,

2012
[Experimental study on biomechanics characteristics of combined collagen tissue engineering tendon].
    Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery, 2005, Volume: 19, Issue:4

    Topics: Animals; Biocompatible Materials; Biomechanical Phenomena; Carbon; Carbon Fiber; Cells, Cultured; Co

2005